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CHAPTER 1 
GENERAl INTRODUCTION 
9 
MICROBIOLOGY 
Chlamydia are obligatory intracellular bacteria and together with the Rickettsia 
occupy a unique niche in the microbial world. For a long time, Chlamydia were 
classified as viruses because of their dependence on the host cell. Since Chlamydia 
contain RNA, DNA and ribosomes (1). a double cell wall (2) and are susceptible to 
antibiotics (1 ,2), these organisms were later classified as bacteria. 
Figure 1 . Chlamydia! growth cycle·. 
1. Elementary body (EBl attachment to host cell (0 hour). 2. Phagocytosis (0 h). 3. Reorganization 
of EB into reticulate body (RB); start of binary fission (8 h). 4. Continued multiplication; dedine of 
host cell DNA synthesis (12-24 h). 5. Visible Vacuolar appearance of inclusion (24-30 h). 6. 
Reorganization of RBs to EBs; inclusion contains RBs and EBs (30 h). 7. Infectivity increases; 
inclusion contains mostly EBs (40 h). 8. Host cell lysis; release of EBs (48-72 h). 
·Adapted from Thompson (17) 
The growth cycle of Chlamydia is shown in Figure 1.The organism has two 
forms, namely the elementary body (EB) which is 0.3 jim and the reticulate body 
(RB) which is 0.9 jim. The infectious, non-dividing, metabolically inactive 
elementary body {EB) can bind to the host cell. According to the presently 
elucidated mechanism, the EB is then taken up into the host cell via endocytosis 
(3,4). In the cytoplasm, the EB is surrounded by a membrane derived from the host 
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cell, but which has been modified considerably by the EB (5). Subsequent fusion 
with phagosome/lysosome is avoided via a mechanism which is not fully 
understood at present and the EB then reorganizes into the reticulate body (RB). 
This RB is strictly intracellular, metabolically active and is able to multiply via binary 
fission. The fissions occurs in the original phagosome which enlarges during this 
process and looks like a vacuole in light microscopy. This vacuole is referred to as 
an inclusion body or in short, an inclusion. During the process of cell division, the 
RB obtains amino acids, sugars and particularly adenosine triphosphate (ATP) from 
the host cell. Chlamydia are unable to synthesize ATP and therefore depend on the 
host cell for their energy requirements (6). After 48-72 h, following a large number 
of fissions, the RBs condense to form EBs and the host cell is lysed. The EBs that 
are released can then infect new host cells. 
CHLAMYDIA SPECIES 
At present, the genus chlamydia comprises three species. These are Chlamydia 
trachomatis, Chlamydia pneumoniae and Chlamydia psittaci. 
To date, 19 different types of C. trachoma tis are known.lnitially, these types were 
distinguished from each other on the basis of antibodies that were formed in mice 
after they had been infected with a single type chlamydia (7). The sera of the mice 
were then investigated for possible cross-reactions with other type of Chlamydia 
using the microimmuunfluorescence assay (MIF). The strength of the (cross)-
reactions also influences the identification. Based on this serological distinction, the 
name serotype or serovar is, therefore, used instead of the type. 
C. pneumoniae is a recently discovered species within the genus Chlamydia 
(8). Although, originally the organism was classified as C. psittaci on the basis of 
the form of the inclusion, the differences between C. trachomatis and C. psittaci, 
summarized in Table I, clearly indicate that C. trachomatis is a separate species. To 
date, only one serovar of C. pneumoniae species is known. 
Many different serovars of the species C. psittaci are known. Under normal 
circumstances C. psittaci is an animal pathogen. The microbiological differences 
between the three chlamydia species are summarized in Table I. 
CliNICAl SPECTRUM 
All C. trachomatis serovars are human pathogens, with the exception of mouse 
pneumonitis serovar. The serovars A, B, Ba and C almost exclusively cause 
trachoma, the most common preventable form of blindness. In certain cases, a 
serovar B was isolated from patients with a genital affection (7, 10). The serovars 
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Table I. Some characteristics of Chlamydia species.' 
Characteristics 
Natural host 
DNA homology (ref. C. pneumoniae) 
Mol% G+C of DNA 
Plasmid 
No. of serovars 
Inclusion morphology 
Glycogen in inclusion 
Folate biosynthesis 
'Adapted from Grayston (9). 
C. trachomatis 
Human (Mouse) 
10 
41/42 
Yes 
19 
Oval, vacuolar 
Yes 
Yes 
Species 
C. pneumoniae C. psittaci 
Human Birds, Mammals 
100 10 
40 41 
No Yes (rare no) 
Unknown (many) 
Oval, dense Variable, dense 
No No 
No No 
Table II. Clinical spectrum of human C. trachoma tis infections'. 
Serotype 
LGV1 , LGV2 , LGV3 
A, B, Ba, C 
O-K 
0-K 
0-K 
Host 
Women 
Men 
Women, Men, Child 
Women 
Men 
Infants 
'Adapted from Thompson et al (17). 
Infection 
Lymphogranuloma venereum 
Trachoma 
Cervicitis 
Urethritis 
Conjunctivitis 
Urethritis 
Post-gonococcal urethritis 
Conjunctivitis 
Conjunctivitis 
Pneumoniae 
Complication 
Vulvar/rectal carcinoma 
Rectal strictures 
Blindness 
Salpingitis 
Perihepatitis 
Epididymitis 
Prostatitis 
Reiter's syndrome 
LGV1, LGV2 and LGV3 are responsible for the lymphogranuloma venereum 
syndrome. Since these 3 serovars grow easily and rapidly in tissue culture, they are 
frequently used as experimental models. Infections with the serovars D-K are the 
cause of the most commonly occurring sexually transmitted diseases. In 30% of 
the cases, such infections follow an asymptomatic course (11-131 which 
contributes significantly towards the spread of the infections. In the majority of the 
patients, the serovars D-K cause symptomatic uncomplicated infections such as 
urethritis or post-gonococcal urethritis in men and urethritis and/or cervicitis in 
women ( 141. In certain cases, advanced stages of uncomplicated C. trachomatis 
infection may cause complications such as epididymitis (15) or pelvic inflammatory 
disease (PI D) ( 16). These complications are important because they can lead to 
infertility. The most important infections that are caused by C. trachomatis are 
summarized in Table II. 
Chlamydia pneumoniae causes respiratory affections varying in severity from 
bronchitis to atypical pneumonia. The respiratory affections caused by C. 
pneumoniae in relation to the age of the infected patient were reported by Grayston 
(9). The most important conclusion was that the course of the disease became 
more severe as the age of the patient increased. Initially, it was assumed that about 
6% of all acute pneumonia in the U.S.A. were caused by C. pneumoniae (18). 
later, it appeared that the period during which the investigations were conducted 
coincided with an epidemiological out-burst in C. pneumoniae infections in the 
Scandinavian countries (19). In the U.S.A. too, in the early 1980s, there was 
probably an epidemiological out-burst in C. pneumoniae infections (40), so that the 
figure for pneumonia caused by C. pneumoniae after 1985 was probably in the 
vicinity of 1%. Recently, a relationship between C. pneumoniae infection on the 
one hand and asthma (20), endocarditis (211 and coronary heart disease (22) on the 
other hand has been established. 
C. psittaci can cause numerous infections in animals. Among others, 
psittacosis {parrot's-disease) and a form of spontaneous abortions in sheep are well 
known. Transmission of C. psittaci from infected animals to humans is possible. 
Although, in some cases an extremely severe form of pneumonia may result after 
infection with C. psittaci, the organism ls not commonly encountered in humane 
infection. A review of the infections caused by C. psittaci in humans was 
published by Storz et al (23). 
DIAGNOSTICS 
A number of methods are available for detecting C. trachomatis infections. The 
method most commonly used is the isolation of C. trachomatis in the tissue culture. 
This method is the currently valid 'golden standard' and all the other methods must 
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be compared with it. The working principle of the method rests on taking a smear 
from the cervix and the urethra using a chlamydia cotton swab attached to a metal 
holder. The swab is then transported to the laboratory in 2-SP medium (24). In the 
laboratory the Chlamydia are cultured on Hela-229 or McCoy cells which are 
incubated for 3 days at 37°C in an atmosphere containing 5% C02 (25). 
Pretreatment of Hela-229 and McCoy cells with OEAE-dextran and cycloheximide 
is essential for optimum harvest 126,27). OEAE-dextran is used to charge the host 
cells positively. This allows the negatively charged EBs to bind easily to the host 
cells. Cycloheximide inhibits protein synthesis in eukaryotic cells. In the presence 
of cycloheximide, the amino acids and sugars present in the host cells are almost 
exclusively available for the growth of Chlamydia. 
Two of the oldest non-tissue culture methods for detecting C. trachomatis 
are the direct immunofluorescence assay (DFA) and the Chlamydiazyme test. In the 
Table Ill. Comparison of the DIF and the tissue culture for the detection of 
cervical or urethral C. trachoma tis infections". 
Study Man(M)I No. of Preva- Sensitivity Specificity 
no. Women(W) patients lence (%) (%) 
w 715 5 76 76 
2 w 253 27 79 88 
3 w 1494 13 73 95 
4 w 527 4 70 62 
5 w 249 9 100 96 
6 w 642 7 60 74 
7 w 968 13 76 65 
8 w 1004 14 90 93 
9 w 301 11 56 56 
10 w 303 23 96 91 
11 M 536 20 78 95 
12 M 236 11 100 82 
13 M 576 20 92 86 
14 M 623 22 90 89 
15 M 200 17 74 98 
"Adapted from Barnes 128). 
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DFA, a direct smear of the swab taken from the patient is prepared on a glass slide. 
After fixing, the slide is stained with fluorescein isothiocyanate-labeled monoclonal 
antibody directed against the major outer membrane protein of C. trachomatis. The 
slides are then examined using a fluorescence microscope. In the Chlamydiazyme 
test, the Chlamydia present in the sample taken from the patient are allowed to 
react with the anti-chlamydia monoclonal antibody coated onto beads. Successive 
incubations are then carried out with rabbit anti-chlamydia lgG and horseradish 
peroxidase-labeled goat anti-rabbit lgG. After incubation with a substrate, the 
developed reaction is read using a spectrophotometer. A comparison of the results 
obtained using these two tests and those obtained using tissue culture are shown 
in Tables Ill and IV. The sensitivity and the specificity of the DFA was generally 
higher than that of the Chlamydiazyme. The performance of both the tests 
increased with an increase in the prevalence of C. trachomatis in the popufation 
that was investigated (281. Other tests for the detection of C. trachoma tis are the 
gene-probe and the polymerase chain reaction (PCRJ. In de gene-probe test, a 
labeled-DNA sequence is hybridized with C. trachoma tis specific rRNA. The DNA-
RNA complex is then isolated from the rest of the sample and the amount of label 
is determined. The sensitivity and the specificity of the gene-probe test as 
Table IV. Comparison of the Chlamydiazyme and the tissue culture for the 
detection of cervical or urethral C. trachoma tis infections'. 
Study Man(MJ/ No. of Preva- Sensitivity Specificity 
no. Women(WJ patients lence (%) (%) 
w 715 5 78 57 
2 w 1489 13 83 84 
3 w 255 21 96 79 
4 w 1059 10 86 39 
5 w 299 16 100 72 
6 w 484 6 89 45 
7 w 514 7 89 72 
8 M 336 20 83 76 
9 M 1011 20 86 80 
10 M 403 19 70 91 
·Adapted from Barnes (281. 
compared with that of tissue culture were 70.6% & 92.7% respectively in men and 
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98.2% & 97.7% respectively in women (29). In the PCR, DNA is first isolated from 
the patient sample after which a C. trachomatis-specific DNA sequence is amplified 
and is made visible in the last step either on a gel or in a blot. Results that were 
obtained using the PCR to detect uncomplicated C. trachomatis infections are 
summarized in Table V. The sensitivity and the specificity were either comparable 
with or better than those obtained using the tissue culture (30-32). 
Table v. Comparison of the PCR and the tissue culture for the detection of 
cervical or urethral C. trachomatis infections. 
Reference Men(M)/ No. of Prevalence Sensitivity Specificity 
no. Women(W) patients (%) (%) (%) 
30 M/W 156 16.7 107 98.5 
31 M/W 220 21.8 104 98.8 
32 M/W 215 11.2 100 93.0 
Another approach for establishing acute infections is the detection of 
antibodies directed against C. trachomatis. The presence of an lgM titer and/or a 
highly increased lgG titer and/or a four-fold seroconversion in lgM, lgG or lgA titer 
in the patient sera indicate a recent infection. The oldest and at the same time also 
the reference method for detecting antibodies directed against C. trachoma tis is the 
microimmuunofluorescence (MIF) assay developed by Wang and Grayston (8,33). 
One of the disadvantages of the MIF is that 12 different antigens must be used 
because in this test system, different C. trachomatis serovars show individual 
characteristic reactions. Another disadvantage of the MIF is the subjective 
interpretation which is inherent to fluorescence microscopy. During the past years, 
different attempts based on enzyme linked immunosorbent assay (ELISA) or 
immunoperoxidase assay (IPA) have been made in order to overcome the 
disadvantages of the MIF (34-36). In general, in these enzyme reactions based and 
thus objective tests, C. trachomatis LGV2 was used as the sole antigen. Views on 
the use of MIF, ELISA or IPA for detecting acute infections vary considerably. Some 
authors reported that there was a good correlation between serology and the tissue 
culture (33,34,36,371. whereas others reported that the correlation was poor 
(35,38). 
The detection of an acute infection caused by C. pneumoniae using the MIF 
is based on serology (39). Tissue culture has several limitations for detecting C. 
pneumoniae. The growth of C. pneumoniae in cell lines is slower than of C. 
trachomatis. The initial isolation from patient samples is also very laborious due to 
the low infectivity of cell line unadapted C. pneumoniae. In addition, as compared 
with C. trachomatis, taking of samples is difficult because the infected region is not 
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always easily accessible. In some studies, a good correlation between the two was 
observed in those cases in which both the results of the serology and the tissue 
culture were available (40.411, whereas a poor correlation was reported in another 
study (42). A possible alternative for detecting C. pneumoniae in patient samples 
is the PCR. To date, the data available on the comparison of the sensitivity and the 
specificity of the PCR with that of the MIF or the tissue culture in patients with 
respiratory affections are rather limited. Therefore, it is not possible to evaluate the 
value of the PCR as a diagnostic tool. 
Complement fixation ICFI is mostly used for detecting C. psittaci. One of its 
disadvantages is the low sensitivity. An additional objection is that antibodies 
directed against the lipopolysaccharide (LPSI of C. psittaci are detected in the CF. 
The LPS in all Chlamydia species is the same. The prevalence of lgG antibodies 
directed against C. trachomatis is about 3% and that against C. pneumoniae is 
about 50%. Since in humans infections caused by C. psittaci are rare, the presence 
of an antibody titer observed in the CF is mostly due to an infection with C. 
pneumoniae or C. trachomatis. 
AIM OF THE STUDY 
The investigations described in this thesis had several alms. As discussed in the 
diagnostics section, the detection of antibodies directed against C. trachomatis 
using the MIF is not only laborious, but the interpretation of the results is also 
subjective. The main objection against using an ELISA or an IPA in which serovar 
LGV2 is used as the sole antigen is that antibodies directed against other serovars 
are either not detected at all or detected unsatisfactorily (34). In the literature too, 
there is no general consensus on the sensitivity and the specificity of serology as 
compared with that of the tissue culture for detecting acute C. trachomatis 
infections. 
In order to overcome these objections, we developed a sensitive enzyme 
linked immunofluorescent assay (ELFA). Antibodies directed against 6 different 
antigens of C. trachoma/is can be detected using the ELFA. The antigens are 
chosen in such a way that antibodies against all C. trachomatis serovars can be 
detected. The contribution made by serology in the diagnostics of acute Chlamydia 
infection was investigated in two groups of patients. Initially, a group of men and 
women with uncomplicated infections who visited the outpatient department of the 
clinic for sexually transmitted diseases in Rotterdam was investigated in order to 
determine whether there was any correlation between the results of serology and 
those of the tissue culture. Later, a group of patients with complicated infections 
was also investigated. This group consisted of patients suffering from pelvic 
inflammatory disease who had been admitted to the department of Gynecology of 
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the Dijkzigt Hospital in Rotterdam. It was also determined whether there was any 
correlation between the results of serology and those of the tissue culture and the 
polymerase chain reaction (PCRI. 
Little is known on the manner in which C. pneumoniae is transmitted from 
one host to another. A possible clue for transmission occurring via aerosols was 
reported by Hyman et al (42). He deduced this from the C. pneumoniae infections 
acquired by the laboratory personnel after an accident involving a centrifuge. 
Undoubtedly, an aqueous intermediate also influences the survival of C. 
pneumoniae during transmission. The spread of the organism must occur very 
efficiently as illustrated by the fact that about 50% of the population in the 
industrialized world has already acquired C.pneumoniae infection between the age 
of 5 and 15 years (39). Therefore, the aim of the subsequent studies was to 
investigate the influence of pH, ion concentrations and temperature on the survival 
of C. pneumoniae. The survival of C. pneumoniae in aerosols under various 
conditions was also investigated using a 114.5 L stainless steel aerosol chamber 
in which both the relative humidity and the temperature could be carefully 
controlled. The survival of other microorganisms including C. trachoma tis in 
aerosols was also investigated in order to determine whether there was any 
correlation with the survival of C. pneumoniae under the same conditions. 
C. trachomatis can be stored best for prolonged periods in SPG medium at 
a minimum temperature of -70°C 143). Optimum survival of C. pneumoniae can be 
achieved by cooling it at 4°C for 4 h prior to freezing 144). However, this method 
is cumbersome and expensive for transport and culture collections. A large number 
of pathogenic bacteria can be stored for a long time with a negligible loss in 
viability by lyophilization in a suitable medium (45,46). Consequently, investigations 
into the optimum media for lyophilization and different methods of freezing that 
may be suitable for the transport and storage of Chlamydia (chapter 61 were also 
pursued. 
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SUMMARY 
The diagnostic value of serum lgG, lgM and lgA in patients with uncomplicated 
urogenital Chlamydia trachomatis infection was compared with isolation in cell 
culture. C. trachomatis specific antibodies were determined with an Enzyme linked 
Immunofluorescent Assay using elementary bodies from C. trachoma tis serotypes 
E,F,H,I,J and LGV2 as antigens. At least two sera from each patient were tested 
and cultures were also established on the same day. Excluding the lgM titers in 
men, significantly more lgG,IgA and lgM and combinations of these antibodies were 
observed in culture positive patients. The sensitivity with which lgG titers in men 
or lgG and/or lgM titers in men and women could be determined, was significantly 
lower using C. trachomatis LGV 2 as the only antigen than when all six antigens 
were used. The presence of ten or more leucocytes in the urine sediment of men 
correlated positively with an lgG or an lgG and/or lgM titer. 
INTRODUCTION 
At present, Chlamydia trachoma/is infection is one of the commonest sexually 
transmitted diseases {STD). C. trachoma tis infection can cause cervicitis, urethritis, 
salpingitis and conjunctivitis 1 . Tissue culture is mainly used to detect C. trachoma tis 
infections and to isolate the microbe. However, tissue culture is only possible at 
centers where the specialized facilities and expertize are available. 
The microimmunofluorescence method {MIF). developed by Wang and 
Grayston 2·3 is considered to be sensitive and specific for the detection of serum 
antibodies against C. trachoma tis. The necessity to use 12 different antigens in the 
MIF and the interpretation with the aid of fluorescent microscopy renders the MIF 
unsuitable for screening large numbers of sera from patients. 
In order to circumvent the disadvantages of the MIF, several serological tests 
for detecting lgG/IgM antibodies in which a single broadly reactive serotype {usually 
LGV 2 ) is used in an enzyme linked immunosorbent assay {ELISA) have been 
described 4•5 ·6 • An immunoperoxidase assay (IPA) is mainly used for the detection 
of lgA {mostly in combination with lgG) antibodies in patients with uncomplicated 
C. trachomatis infection'·'. In the IPA also, C. trachoma tis LGV, is the only antigen 
that is used. The use of only a single antigen brings with it the danger that 
infections caused by other serotypes may not be detected serologically'''. 
Several years ago, an enzyme linked immunofluorescent assay {ELF AI with 
a higher sensitivity than of the ELISA has been reported'. We have developed an 
ELFA in which the C. trachomatis serotypes E,F,H,I.J and LGV2 were used as 
antigens. The six serotypes were chosen to enable the detection of antibodies 
against all C. trachomatis serovars3 • Using this ELFA, titers of lgG, lgM, and lgA 
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antibodies against C. trachomatis were determined in patients with a high 
prevalence of C. trachomatis infections. In addition, the results obtained using the 
six antigens were compared with those obtained using LGV, as the only antigen. 
Since cross-reactivity in ELISA reactions between the antibody response to 
C. trachomatis and C. pneumoniae have been described 10 , the lgG response of 54 
and the lgM response of 42 sera against C. pneumoniae antigen was determined 
and correlated with ELFA titers. Finally, ELFA and microimmunofluorescence IMIF) 
were compared using 51 sera and C. trachomatis E as only antigen. 
MATERIALS AND METHODS 
Patients 
The patient group comprised 140 women and 207 men who attended the clinic for 
sexually transmitted diseases in Rotterdam. At least two sera were obtained from 
each patient at approximately ten days interval. On the same day that serum was 
obtained, the patients were also examined for the presence of other sexually 
transmitted diseases and C. trachomatis cultures were established. Further, the 
numbers of leucocytes in cervical gram preparations from women and in the urine 
sediment of men were determined. Ten or more leucocytes at a magnification of 
x1 000 in the cervical gram preparation and ten or more leucocytes at a 
magnification of x250 in the urine sediment were regarded as positive. Presense 
of ten or more leucocytes in the urine sediment of men, in the absence of 
gonococci, was clinically diagnosed as urethritis. 
Chlamydia Strains and Antigen Purification 
C. trachomatis serotypes E (strain UW-5/Cx), F (strain IC-Cal-3), H (strain UW-
4/Cx), I (strain UW-12/Ur), J (strain UW-36/Cx), LGV 2 (strain 343/Bu) were 
cultured in cycloheximide treated McCoy cells as described by Ripa and Mardh". 
After culturing for 48-72 h, the cells were sonicated and the chlamydia elementary 
bodies IEBs) were partially purified by differential centrifugation at 500 x g for ten 
min and at 30000 x g for 30 min and centrifuged at 53000 x g for 1 h through a 
30% urografine solution 13.9 g/1 00 ml sodium amidotrizoate, 26 g/1 00 ml 
meglumine amidotrizoate, 146 mg/100 mllodine). Chlamydia that were more than 
95% pure were subsequently washed once with PBS and stored in PBS at -80 °C. 
Protein concentration of the solution was determined according to the method of 
Lowry12 . 
Chlamydia trachomatis culture 
C. trachomatis was isolated from patient material according to the method of 
Thewessen et al13 • Briefly, after mixing, a 0.2 ml sample was distributed over 
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mono layers of He La 229 cells in two wells of a microliter plate. Prior to inoculating 
the patient material, the monolayers were pretreated with 15 pl/ml DEAE in Hanks 
balanced salt solution !HBSS) (Flow Lab., Irvine, Scotland). After centrifugation for 
1 h at 3000 x g, the medium was replaced with Eagles modification of minimal 
essential medium containing 10% FCS (Hyclone Laboratories lnc.,Logan, USA). 1% 
glutamin (Flow), 1% vitamins (Flow), 0.42 M glucose, 0.5 pg/ml cycloheximide 
(Sigma Chern., St Louis, Miss.), 18 pg/ml gentamicin, 23 pg/ml vancomycin and 
2.5 pg/ml amphotericin B. Plates were incubated for 48 h at 37 °C and 
subsequently fixed and stained with anti-C. trachomatis monoclonal antibody 
(Microtrak; Syva Co., Palo Alto, Calf.) and examined for inclusions. 
Microimmunofluorescence 
The MIF was performed using a modified procedure as that described by Wang and 
Grayston3 . Dots of viable C. pneumoniae or C. trachoma tis strain E EBs were 
spotted on a 8 slide multitest well (Flow). After drying the slides were fixed in 
acetone and air dried. Subsequently, the slides were incubated for 30 min at 37 °C 
with 30 pi serum starting at a 1:8 dilution. The slides were rinsed thrice with PBS 
and air dried. Hereafter, the slides were incubated for 30 min at 37 oc with 30 pi 
1 :40 anti-human lgG FITC (Boehringer, Mannheim, Germany) or with 30 pi 1 :40 
anti-human lgM (Boehringer), rinsed thrice and examined for fluorescent EBs. 
Positive sera were quantified using two fold dilutions. The MIF lgG titers of 54 sera 
and the MIF lgM titers of 42 sera against C. pneumoniae were determined in the 
same range as those observed for ELFA lgG or lgM titers. The correlation between 
C. trachomatis and C. pneumoniae titers was calculated. The sera for comparing 
ELFA and MIF were chosen on the basis of known ELFA titers such that al observed 
ELFA titers were represented. C. trachomatis E was chosen as antigen since it 
occurs most frequently in urogenital infections14. 
ELFA 
Wells of PVC microliter plates (Dynatech Lab. Inc., Alexandria VA) were coated 
with 50 pi of a 10 pg/ml EB suspension in 0.1 M carbonate/bicarbonate buffer (pH 
9.6). After an overnight incubation at 4 °C, the unoccupied binding sites were 
blocked by incubation for 2 h at 37 °C with PBS containing 2% BSA (Sigma). 
Subsequently, the plates were rinsed once with PBS containing 1% BSA and 
0.05% Tween 20 (PBST) and subsequently incubated with 50 pi diluted serum 
(1 :250 lgM/IgA and 1:1000 lgG) at 22 °C for 45 min. The plates were then rinsed 
thrice with PBST and incubated at 22 oc for 45 min with either 50 pi of 1:8000 
dilution of anti-human lgG biotin (Boehringer) or with 50 pi of 1:1000 dilution of 
anti-human lgA (Amersham, Bucks., U.K.) or with 50 pi of 1 :250 dilution of anti-
human lgM which had been coupled toP-galactosidase (Sigma) via N-succinimidyl-
3-(2-pyridyldithiol propionate (SPDP, Boehringer). The plates were then rinsed thrice 
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with PBST and those for lgG and lgA titer determination were incubated for a 
further 45 min at 22 °C after addition of 50 .ul of 1:4000 dilution of streptavidin 
,8-galactosidase (Boehringer) and subsequently rinsed thrice with PBST. The final 
step comprised a 1 h incubation at 37 °C after addition of 100 pi of 0.25 mg/ml 
4-methylumbelliferyl ,8-0-galactoside (Sigma) in a solution containing 44 mM 
K2HP04 , 55 mM KH 2P04 , 4 mM MgCI2 (pH 7.6). The reaction was stopped by 
adding 100 pi of 1 M Na2C03 • Fluorescence was measured at 480 nm using 
FLUOROSKAN 1 (Flow). The reproducibility of the ELFA was tested for every 
antigen by measuring a positive and an intermediate patient serum with a MIF lg 
titer of 1/1024 and 1/64 respectively. 
The negative cut-off point was determined using 80 sera from blood donors 
(35 women and 45 men). The sera were tested individually using the same protocol 
as above with a 1:250 dilution for lgM/IgA determination and a 1:1000 dilution for 
lgG determination. The negative cut-off point was set at the value at which 95% 
(76 of the 80) of the donor sera were negative. Positive sera titers from the patient 
group were quantified using two-fold dilutions such that the test values were on 
or just above the cut-off point. 
Statistical analysis 
Statistical significance was calculated using the Fisher exact test. The correlation 
between ELFA and MIF, and between C. pneumoniae and C. trachoma tis titers was 
calculated by linear regression after a 21og transformation. 
RESUlTS 
Reproducibility of the ELFA 
Reproducibility of the ELFA was tested for every antigen by measuring the absolute 
fluorescence of a positive and an intermediate serum ten times over a period of four 
days. Using C. trachomatis LGV2 as the only antigen in the MIF, the positive serum 
had an lg titer of 1:1024, whereas the intermediate serum had an lg titer of 1:64. 
The reproducibility of the test for determining lgG antibodies is shown in Table 1. 
The mean, the standard deviation (SD) and the coefficient of variance SO/mean) 
were within the criteria set by Hart15 • The reproducibility of the ELFA for 
determining lgA and lgM antibodies also satisfied similar criteria (results not 
shown). The positive and the intermediate sera were subsequently included in every 
test. The test was repeated if deviations of larger than 10% in the mean value of 
the positive serum and/or larger than 30% in the mean value of the intermediate 
serum were observed. 
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Table 1: Reproducibility of enzyme linked fluorescent 
assay (ELFA) for determining lgG antibodies. 
Pos. serum lnterm. serum 
Antigen (fluor. units) CV% • (fluor. units) CV% * 
E 6530±335 5.1 2958±514 17.4 
F 6379±405 6.3 2682±412 15.4 
H 6674±252 3.8 2571±416 16.2 
6018±496 8.2 2519±514 20.4 
J 7412±226 3.0 3056±314 10.3 
LGV2 7198±324 4.5 2972±294 9.9 
• Coefficient of variance (standard deviation/mean). 
Comparison between ElFA and MIF 
Using C. trachomatis E EBs as antigen there was a high correlation between lgG 
titers of 51 tested sera in MIF as compared with the titers obtained in ELFA (fig 1 ). 
The correlation coefficient was 0.88. There seemed to be no major differences in 
the sensitivity of ELFA and MIF. 
Cell culture 
C. trachoma tis was isolated from 42 out of the 140 (30.0%) women and from 47 
out of the 207 122.7%) men. 
ELFA 
1. lgG, lgM or lgA antibodies directed against C. trachoma tis. 
Antibodies of the lgG class directed against the C. trachomatis antigens E,F,H,I,J 
and LGV 2 at least in one of the tested sera of the patients were observed in sera 
of 23 (48.9%) men who had positive culture and in sera of 32 (20.0%) man who 
had negative culture (p = 0.0003). In women, 31 (73.8%) and 39 (39.8%) 
respectively were observed to be positive (p = 0.0004). When C. trachomatis 
LGV 2 was used as the only antigen, the sensitivity of lgG antibody determination 
in men was lower than that using all six antigens (E,F,H,I,J and LGV2 ), but the 
specificity remained the same (Table 2). In this respect, no statistically significant 
differences were observed in women. lgG antibodies against C. trachomatis were 
more frequently observed in the sera of men (43.1 %) with an increased number of 
leucocytes in the urine sediment than in sera of men 120.1 %) without any increase 
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Figure 1. Scatter diagram of lgG titers against C. trachomatis strain E EBs obtained by ELFA and 
Mif. 
in the number of leucocytes (p = 0.025). In women there was no correlation 
between the number of leucocytes in the gram preparation of the cervix and an lgG 
titer in the serum. Serum lgA antibodies directed against C. trachomatis antigens 
E,F,H,I,J and LGV2 were observed in 23 (48.9%1 men with positive culture and in 
46 128.8%) men with negative culture (p = 0.013) and in 23 (54.8%1 women with 
positive culture and in 28 (28.6%1 women with negative culture (p = 0.004). Both 
in men and women, there was no correlation between the increased number of 
leucocytes and the presence or the absence of an lgA titer in the serum. 
Since only in 3 of 47 (6.4%) culture positive men and in 9 of 160 (5.6%1 culture 
negative men, lgM antibodies were found (see also Table 2), no differences in the 
frequency between culture positives and culture negatives were observed. In 
women there was a significant difference (p = 0.016). 
2. lgG and/or lgM and/or lgA antibodies directed against C. trachomatis. 
Using all six antigens, lgG and/or lgM antibodies were observed more frequently in 
the group of patients that had positive cultures than the group that had negative 
cultures (men 53.2% and 29.0% respectively, p =0.0001, and women 83.3% and 
48.0% respectively, p = 0.000081. In the group of patients (men and women) that 
had positive cultures, lgG and/or lgA, lgA and/or lgM, lgG and/or lgA and/or lgM 
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Table 2: Sensitivity and specificity of ELFA compared with tissue culture. 
1. lgG, lgM or lgA antibodies directed against Chlamydia trachoma tis. 
lgG lgA lgM 
Sens.(%1 Spec.(%) Sens.(%1 Spec.(%) Sens.(%1 Spec.(%) 
Men 
LGV 2 as the only 25.5 • 83.8 42.6 73.8 6.4 
antigen# 
All antigens + 48.9 80.0 48.9 71.3 6.4 
Women 
LGV 2 as the only 54.8 69.4 50.0 72.4 31.0 
antigen# 
All antigens + 73.8 60.2 54.8 71.4 38.1 
Sensitivity and specificity of the tissue culture is set at 100%. 
* P=0.032 as compared with sensitivity 'all antigens' 
Titer against C. trachoma tis LGV 2 in at least one serum/patient. # 
• Titer against at least one of the antigens E, F, H, I, I, J, LGV2 in at least one 
serum/patient. 
96.3 
94.4 
86.7 
82.7 
The differences in the sensitivity are significant for the difference > = 23.4 % in 
men and > = 21.4 % in women (see also Table 3). 
The differences in the specificity are significant for the difference > = 11.2 % in 
men and > = 15.3 % in women (see also Table 3). 
Table 3: Sensitivity and specificity of ELFA compared with tissue culture. 
2. lgG and/or lgM and/or lgA antibodies directed against Chlamydia trachoma/is. 
lgG and/or lgA lgG and/or lgM lgA and/or lgM lgG and/or lgA 
and/or lgM 
Sens.(%1 Spec.(%) Sens.(%) Spec.(%) Sens.(%1 Spec.(%) Sens.(%1 Spec.(%) 
Men 
LGV2 as the 
only antigeen # 
All antigens + 
Women 
LGV, as the 
only antigen # 
All antigens + 
55.3 64.4 
63.8 61.3 
66.7 57.1 
83.3 51.0 
29.8' 81.9 
53.2 77.5 
61.9" 62.2 
83.3 52.0 
Sensitivity and specificity of the tissue culture is set at 100%. 
* 
•• 
P =0.036 as compared with sensitivity 'all antigens'. 
P =0.049 as compared with sensitivity 'all antigens' . 
46.8 
51.5 
66.7 
69.0 
Titer against Chlamydia trachomatis LGV 2 in at least one serum/patient. 
71.3 57.4 
67.5 63.8 
66.3 78.6 
61.2 88.1 
# 
t Titer against at least one of the antigens E, F, H, I, J, LGV, in at least one serum/patient. 
62.5 
58.8 
45.9 
44.9 
The differences in the sensitivity are significant for the difference > = 23.4 % in men and > = 21 .4 % in 
women (see also Table 2). 
The differences in the specificity are significant for the difference > = 11.2 % in men and > = 15.3 % in 
women (see also Table 2). 
were more frequently observed than in the group that had negative cultures (results 
not shown). 
The sensitivity with which lgG and/or lgM antibodies were determined in men 
(p = 0.036) and in women (p = 0.049) using LGV 2 as the only antigen was lower 
than that using all six antigens (Table 3). In men (49.0%) with an increased number 
of leucocytes in the urine sediment, lgG and/or lgM titer was observed more 
frequently than in men (22.2%) without an increased number of leucocytes (p = 
0.014). 
In women, the determination of lgG antibodies, in contrast to the 
determination of lgM and lgA antibodies directed against C. trachomatis, 
contributed significantly towards the sensitivity of the test in comparison with cell 
culture (Tables 2 and 3). However, the specificity was lowest as compared with 
lgA and lgM. 
We found no correlation between lgG or lgM antibodies against C. 
trachomatis determined with ELFA in respectively 54 and 42 sera compared with 
lgG or lgM antibodies in the same sera against C. pneumoniae determined with MIF. 
The correlation coefficients ranged, depending on the C. trachoma tis antigen used, 
from 0.26 to 0.31 for lgG antibodies and from 0.0 to 0.1 for lgM antibodies. In 
48.1% of the sera an lgG titer indicating a previous C. pneumoniae infection was 
observed. This percentage is in agreement with that reported in previous studies 10 • 
DISCUSSION 
When the men in the present study were divided into urethritis positive/tissue 
culture positive and urethritis positive/tissue culture negative groups, a sensitivity 
of 51.9% and a specificity of 66.7% as compared with tissue culture were 
observed in the urethritis positive group. Schoenwald et al 6 reported an ELISA test 
which had a sensitivitY of 72.9% and a specificity of 54.0% in men with urethritis, 
of whom 32.3% had a positive C. trachomatis culture. In women with cervicitis 
(12.7% with posit'1ve tissue culture), Schoenwald et al 6 observed a sensitivity of 
91.1% and a specificity of 53.9%. In the present study, a sensitivity of 81.3% and 
a specificity of 66.6% were observed in women with cervicitis (50% with positive 
tissue culture). In order to determine the negative cut-off point, sera that were 
known to be negative were used in ELISA by Schoenwald et al6 • In the general 
population, the incidence of C. trachoma tis is 5-13% 16 • In our study, the negative 
cut-off point that was established using sera ol blood donors was probably higher 
thereby decreasing the sensitivity and increasing the specificity of the test. 
In the current study, the values of serum lgA antibodies in C. trachomatis 
culture positive patients were lower than those observed by others. Cevenini et al. 17 
and Hagay et al. 7 reported a sensitivity ol 94.1% and 83.0% respectivily and a 
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specificity of 78.0% in tissue culture positive men with urethritis. Although in our 
group of patients only 53.3% of the tissue culture positive men suffered from 
urethritis, an lgA titre was observed in only 48% of these urethritis positive men. 
The difference in the cut-off point, may be a possible explanation for the observed 
discrepancy in values obtained for lgA. 
The results of lgM antibody titer determination in women, that were obtained 
using the ELFA, corroborated the results reported by others 18· 19 • The sensitivity of 
the test was low, but the specificity was high. 
In this study it has been demonstrated that an ELFA in which C. trachomatis LGV, 
was used as the only antigen had a significantly lower sensitivity for detecting lgG 
and/or lgM antibodies as compared with ELFA in which a selected number of C. 
trachoma tis antigens were used. Mahoney et al. 5 had already indicated that the use 
of only C. trachomatis LGV 2 antigen in an ELISA was insufficient to detect 
antibodies against all serotypes. These authors were unable to detect antibodies 
against C-complex antigens. 
Significant sera-conversions of lgG, lgA or lgM antibody titers were scarcely 
observed. On the one hand, it is possible that the period of time over which the 
sera were collected was too short, whereas on the other hand, in a population in 
which the incidence of C. trachomatis is high, increased background serum titers 
of lgG exist and anti-Chlamydia antibodies may persist for prolonged periods20 • 
Frequently after reinfection, lgM antibodies in the serum cannot be demonstrated, 
but the lgG antibody titer increases early in the infection. Since the general 
practitioner is frequently consulted in the later stage, sera-conversion is no longer 
demonstrable. The half-life of lgA antibodies in the serum is 6-7 days". After the 
patient has been treated, a decrease in the lgA titer may be used to monitor the 
effectiveness of the therapy. We observed only a scarce decrease in lgA titer in the 
period during which the sera were collected. 
In comparison with the tissue culture, the best sensitivity of the ELFA both 
in men and women was observed for determining lgG and/or lgM and/or lgA 
antibodies, but the specificity was low. Although there were several improvements 
in our test as compared with those already reported by other authors4 ·5 · 6 .7· 8 , our 
results corroborated with those of Schachter et a1. 19 , leading to the conclusion that 
determination of lgG and/or lgM and/or lgA antibody titers in a patient population 
with a high prevalence of C. trachomatis were unsuitable for tracing acute 
infections. 
After the discovery of C. pneumoniae species and the observed high 
prevalence of lgG antibodies in the western population, it was reported that 
antibodies directed against C. trachomatis and C. pneumoniae could only be 
distinguished using MIF10 • In ELISA and ELFA, cross-reactions are mainly caused 
by antibodies directed against lipopolysaccharide (LPS). In principle, these reactions 
can be avoided in two ways. Ladany et al. 22 described a method whereby LPS was 
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extracted out after which only specific anti-MOMP antibodies could attach. It is also 
possible to use native unfixed EBs as antigen instead of formaline fixed EBs. The 
LPS is then spontaneously removed from the membrane23 • Since we could not 
demonstrate any cross-reactions between the species C. trachomatis and C. 
pneumoniae, and since we found good agreement between ELFA and MIF lgG 
titers, it is possible to use an ELFA or eventually an ELISA technique incorporating 
viable EBs as antigen to trace antibodies directed against C. trachomatis. 
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SUMMARY 
Objective: Detection of acute phase antibodies against C. trachomatis and its 
comparison with tissue culture or polymerase chain reaction IPCRI on samples of 
cervix and urethra obtained from patients with pelvic inflammatory disease IPID). 
Study design: In the academic hospital Dijkzigt, Rotterdam, The Netherlands, 
prospective investigations were performed on 49 consecutive patients who were 
admitted with the diagnosis of PID. Infections with C. trachomatis were traced 
using tissue culture, PCR or by determining acute phase JgG and lgM antibodies. 
Differences between the sensitivities of serology and tissue culture or PCR were 
calculated using the Fisher exact test. 
Results: C. trachomatis infection was detected more often in PID patients using 
serolgy in comparison with PCR IP=0.028) or tissue culture IP=0.005). All 
patients who were positive lor C. trachomatis in the PCR and 3 of the 4 patients 
who were positive in tissue culture also had acute phase antibodies. 
Conclusions: Establishing acute C. trachomatis infections in PID patients on the 
basis of serology was superior to either tissue culture or PCR on samples obtained 
from cervix and urethra. 
INTRODUCTION 
The role of Chlamydia trachomatis as the cause of pelvic inflammatory disease 
(PI D) is well known 11 ,21. In a Norwegian study, it was observed that more than 
50% of the PID cases were caused by Chlamydia, whereas Neisseria gonorrhoeae 
played a more subordinate role 131. A complicated C. trachomatis infection often 
begins as a clinical benign condition which in most cases remains undiagnosed. 
This can, in a later stage of infection, lead to tubal damage and subsequently to 
infertility. In some cases, C. trachomatis can be cultured from the fallopian tubes 
141. from the endometrium 151 or the peritoneal fluid (6). In a recent Swedish study, 
C. trachoma tis in samples of tubae and endometrium in a group of infertile women 
were detected more efficiently using direct immunofluorescence IDFA) than in 
tissue culture 171. 
In the Dutch setting, obtaining samples from tubae and endometrium is often 
regarded as imposing an unnecessary burden on the patient. Moreover, because 
culturing of C. trachomatis from the samples of tubae and cervix in an acute PID 
appears to be !ess sensitive {7}, one would attempt to establish the infection on the 
basis of serology. In this study, enzyme·linked fluorescent assay IELFA) was used 
to detect acute phase !gM and lgG antibodies instead of the more laborious 
microimmunolluorescent IMIF) technique 18). The results were compared with C. 
~rachomatis eel! culture of cervix/urethra samples and with the results of a C. 
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trachomatis specific polymerase chain reaction on cervix/urethra samples. 
MATERIALS AND METHODS 
Patients 
Forty-nine women who had been admitted consecutively at the Department of 
Obstetrics and Gynecology of the Academic Hospital Rotterdam-Dijkzigt and who 
satisfied the clinical criteria for acute PID were enrolled into this study. The clinical 
diagnosis of PID was based on the presence of at least the first four and one or 
more of the following criteria 15-9): 
1. History of lower abdominal pain. 2. Presence of lower abdominal tenderness. 3. 
Cervical motion tenderness. 4. Adnexal tenderness. 5. Body temperature >38°C. 
6. Leucocytosis > 10500/mm'. 7. Erythrocyte sedimentation rate (ESR) >20 
mm/first hour. 8. Abnormal vaginal discharge. 9. Abnormal vaginal bleeding. If the 
diagnosis, on basis of clinical criteria, was doubtful, PID was established by 
laparoscopy. In 17 patients (34. 7%) the diagnosis of PID was confirmed in this 
manner. 
Samples for C. trachomatis cultures and for PCR on Chlamydia-specific DNA were 
obtained using a swab with a metal holder (Medical Wire & Equipment Co. Ltd., 
Wiltshire, UK) and transported in 2SP medium containing 0.2 M sucrose (Merck, 
Darmstadt, Germany), 49 mM glutamine !Sigma Chern. Co. St. Louis, MO), 10% 
foetal calf serum (FCS) (Hyclone Lab. Inc. Logan, Utah), 18 Jig/ml gentamicin, 23 
Jlglml vancomycin and 2.5 Jlg/ml amphotericin Bin 20 mM phosphate buffer and 
stored at 4°C if cultured within 24 h or frozen at -70°C, if it was not possible to 
culture within that period. In each patient at least two sera were collected at about 
10 days interval for the estimation of lgG and lgM antibodies against C. 
trachomatis. Prior to sampling for C. trachomatis and Chlamydia-specific DNA, 
samples were collected from cervix, urethra and rectum for culture of N. 
gonorrhoeae. 
C. trachomatis culture 
C. trachomatis was isolated from samples obtained from the patients according to 
the method described by Thewessen et al (9). A microtiterplate with a monolayer 
of HeLa 229 cells was preincubated with 15 Jlg/ml DEAE in Hank's Balanced Salt 
Solution (Flow Labs., Irvine, Scotland). After mixing, 0.2 ml/well of each 
cervix/urethra sample from the patient was setup in duplicate. The plates were then 
centrifuged at 3000 x g for 1 h and subsequently cultured for 48 h in Eagle's 
modification of minimal essential medium (Flow) containing 10% FCS, 2 mM 
glutamine, 1% vitamins, 0.42 M glucose, 0.5 ,ug/ml cycloheximide (Sigma), 18 
J.lg/ml gentamicin, 32 .ug/m! vancomycin and 2.5 ,ug/ml amphoterlcin 8, The plates 
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were then fixed and stained with anti-C. trachomatis monoclonal antibodies (Microt-
rak, Syva Co., Palo Alto, Calf.) and examined for inclusions. 
C. trachomatis-specilic polymerase chain reaction (PCRI 
The PCR on C. trachomatis-specilic DNA was performed according to the method 
described by Claas et al (10). DNA was extracted from 0.5 ml cervix/urethra 
sample from each patient. Two sets of oligonucleotide primers were used. The first 
set (R1 = GTGGATAGTCTCAACCCTAT, R2 = TATCTGTCCTTGCGGAAAAC), 
was derived from 16S rRNA gene sequences of C. psittaci (11) and generated 208-
bp amplified products with all three Chlamydia species. The second set (T1 = 
GGACAAATCGTATC TCGG, T2 = GAAACCAACTCTACGCTG was derived from 
sequences of the common endogenous plasmid of C. trachomatis (121 and 
generated 517-bp amplified products with all known C. trachomatis serovars. After 
40 cycles, the amplification product was analysed on a 2% agarose gel. 
Enzyme-linked fluorescent assay (ElFAI 
The ELFA was performed as described previously (13). Wells of PVC microtiter 
plates were coated with 50 pi of a 10 pg/ml elementary bodies (EB) suspension of 
the C. trachomatis serotypes E (strain UW-5/cx), F (strain IC-Cal3), H (strain UW-
4/Cx). I (strain UW-12/Ur). J (strain UW-36/Cx) and LGV2 (strain 343/Bu) in 0.1 
M carbonate/bicarbonate buffer (pH 9. 6). After an overnight incubation at 4 °C, the 
unoccupied binding-sites were blocked with PBS containing 2% BSA. The plates 
were subsequently rinsed with PBS containing 1% BSA and 0.05% Tween-20 
(PBST) and incubated with 50 pi diluted test serum (1 :250 for determining lgM and 
1:1000 for determining lgG) at 22 °C for 45 min. The plates were then rinsed with 
PBST and incubated at 22°C for 45 min with either 50 pi of 1:8000 dilution of 
anti-human lgG biotin (Boehringer, Mannheim, Germany) or with 50 pi of 1 :250 
dilution of anti-human lgM which had been coupled to li'-galactosidase. The plates 
were then rinsed with PBST and those for lgG titer determination incubated for a 
further 45 min at 22°C after addition of 50 pi of 1:4000 dilution of streptavidin li'-
galactosidase (Boehringer) and subsequently rinsed with PBST. The final step 
comprised a 1 hr incubation at 37°C after addition of 100 pi of 0.25 mg/ml 4-
methylumbelliferylli'-D-galactoside (Sigma) in a buffer containing 44 mM K2HP04 , 
55 mM KH 2P04 , 4 mM MgCI, (pH 7.6). The reaction was stopped by adding 100 
pi of 1 M Na2C03 • Fluorescence was measured at 480 nm using FLUOROSKAN 1 
(Flow). 
The criteria for an acute infection were: an lgM titer ;,: 1 :500 (corresponding with 
a MIF titer ;,: 1 :32). and/or an JgG titer ;,: 1:16000 (MIF titer ;,: 1 :512), and/or a 
four-fold increase/decrease in lgM and/or a four-fold increase in lgG titer. The cut-
off points of an acute infection as determined by MIF were described by Grayston 
et al.(14). 
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Statistical analysis 
Statistical differences between the sensitivity of tissue culture and PCR for C. 
trachomatis on the one hand and C. trachomatis serology on the other hand were 
calculated using the Fisher exact test. 
RESULTS 
Seven out of the 49 patients were positive in C. trachoma tis culture and/or PCR on 
C.trachomatis- specific DNA. Four patients were positive in culture. In 3 of these 
patients, C. trachomatis-specific DNA could be detected. Three additional patients 
were positive in PCR only. N. gonorrhoeae was cultured from the samples of cervix 
and/or urethra in 13 out of the 49 (26.5%1 patients. In 3 out of of the 49 (6.1 %1 
patients there were, in culture, indications of both chlamydia! and gonococcal 
infections. 
The prevalence of acute phase lgM and/or lgG antibodies against C. trachomatis is 
shown in Table I. Combining high lgG/IgM titers with an increase or decrease in lgM 
titers and an increase in lgG titers showed an acute antibody titer in 32.7% of the 
patients. A total of nine patients were only positive when using serology. There 
was a statistically significant difference between the sensitivity of C. trachoma tis 
culture as compared with C. trachomatis serology (p = 0.0051 and between the 
sensitivity of PCR as compared with serology (p = 0.028). In all 6 patients in whom 
C. trachoma tis-specific DNA was demonstrated in the PCR and in 3 out of the 4 
patients in whom C. trachomatis cultures were positive, acute phase antibodies 
were also observed. In 2 out of the 6 PCR-positive patients, an lgG titer ;,: 
1:16000 was observed, in 2 patients a four-fold increase in the lgG titers were 
observed and in 2 patients, both a four-fold increase in the titers of lgM and lgG as 
well as an lgM titer of 1:1000 and an lgG titer of 1:16000 were observed. Three 
Chlamydia culture/PCR negative patients were found to be positive in both N. 
gonorrhoeae culture as in C. trachoma tis serology. 
DISCUSSION 
In the literature the best methods to trace the cause of PID appears to be tissue 
culture or direct immunofluorescence on the samples from tubae or endometrium 
(7, 151. In the Netherlands, obtaining samples from tubae for detection of C. 
trachomatis is generally considered as imposing an unnecessary burden on the 
patient. Moreover, Thejls et al 171 reported that the sensitivity of primary culture for 
C. trachomatis established from the samples from tubae or endometrium was 
limited as compared with the sensitivity with which chlamydia antigens were 
demonstrated using direct immunofluorescence. In another study, it was reported 
41 
Table I. Distribution of acute phase antibodies against C. trachomatis in 
patients with pelvic inflammatory disease. 
Antibody group 
1 . lgM 2 1/500 
2. lgG 2 1/16000 
3. four-fold increase/decrease in lgM 
titer 
4. four-fold increase 
in lgG titer 
5. 1 and 2 combined 
6. 3 and 4 combined 
7. 1 ,2,3 and 4 combined 
8. Negative 
Number of patients (%) 
6/49 (12.2%) 
5/49 (10.2%) 
4/49 (8.2%) 
9/49 118.4%) 
9/49 (18.4%) 
11/49 (22.4%) 
16/49 (32. 7%) 
33/49 (67.3%) 
that the samples from tubae and endometrium had to be passaged several times 
in culture before C. trachoma tis could be detected I 15). 
In our study, C. trachomatis was cultured from the cervix in 8.2% of the patients 
with PID, whereas in other studies C. trachomatis was isolated from the cervix in 
36-49% of patients with the same diagnosis 11, 16). As the sensitivity of the C. 
trachomatis-specific PCR for culture confirmed urogenital specimens was shown 
to be excellent (1 0), the demonstration of C. trachoma tis-specific DNA in the PCR 
might have increased the sensitivity of tissue culture of samples from the cervix. 
Therefore, together with Chlamydia-culture we performed PCR on all samples. 
Chlamydia-specific DNA was demonstrated in 6 112.2 %) of the patients. 
Combination of tissue culture and PCR demonstrated infection with C. trachoma tis 
in the cervix as a possible cause of PID in 7 (14.3%) patients but was lower than 
that reported previously (1 ,5, 15). However, in our opinion, this percentage (14.3%) 
was the maximum that could be achieved using this form of detection in the 
patients in this study. 
In order to improve the sensitivity for detection of acute C. trachomatis infection 
in PID patients without using invasive techniques, acute lgG/IgM titers against a 
representative set of chlamydia! antigens were determined. From the figures in 
Table I, it can be seen that a combination of high lgM/IgG titers and four -fold 
increase/decrease of lgM titer and a four-fold increase in lgG titer had the highest 
sensitivity for detecting acute phase antibodies against C. trachomatis (32. 7% of 
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the patients). Determining the conversions in lgG titers 118.4%) made the largest 
contribution. This was followed by high lgM titer 112.2%). Determining high lgG 
titer (1 0.2%) and conversion in lgM titer (8.2%) made minor contributions. In two 
patients with an acute antibody titer, only high lgG titers were observed. It was 
previously reported that lgG antibodies can remain in the circulation for a long 
period after C. trachomatis-caused PID (17). Although these two patients had 
satisfied the clinical criteria for an acute PID, it could not be totally excluded that 
both these patients had chronic C. trachoma tis infection. Serum conversions, often 
observed in our group of PID patients, were hardly observed in patients with 
uncomplicated urogenital C. trachomatis infections (13). To our knowledge, serum 
conversions were not determined in the previous investigations on PID patients. 
However, it was observed, that the average titer of lgM/IgG antibodies in a group 
of PID-patients in whom C. trachomatis cultures were positive was higher than 
that in a group of PID-patients from whom no C. trachomatis could be cultured 
I 17). This was in accordance with our results, as we observed acute phase titers 
in all but one culture/PCR positive patients. 
In 26.5% of the patients, N. gonorrhoeae was isolated from the cervix. In our 
study, the incidence of gonorrhea was similar to that observed by others 11 ,4,5). 
Alltogether in 24 149%1 out of 49 PID patients an infection caused by C. 
trachoma tis and/or N. gonorrhoeae could be detected. 
The best method to establish the diagnosis for the suspected causes of PID was 
DFA on samples from tubae and endometrium (7). In the present study, the number 
of infections demonstrated using serology was comparable to that demonstrated 
by Thejls et al. using DFA (7). In our hands, the role of C. trachomatis as a possible 
cause of PID was demonstrated with a higher sensitivity using serology than either 
culturing of or PCR on samples from the cervix. As compared with DFA on the 
samples from tubae or endometrium, serology also hardly imposes any unnecessary 
burden on the patient. 
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SUMMARY 
The influence of variations in the pH, NaCI concentration, temperature, 
concentration of calcium (Ca 2+1 and magnesium 1Mg2+1 ions on the survival of 
Chlamydia pneumoniae elementary bodies (EBI outside the host cells was 
investigated. The survival was determined after various incubation periods by 
counting inclusion forming unit (IFU) after culturing for 72 hr on mono layers of HL 
cells. The normal physiological conditions were restored prior to infecting the HL 
cells with C. pneumoniae. A decline in the infectivity of C. pneumoniae EB were 
observed at pH values of lower than 5 and higher than 8 or at NaCI concentrations 
of lower than 80 mM. The viability of C. pneumoniae EB in SPG medium decreased 
as the temperature and/or incubation period increased. Incubation temperatures of 
up to 20°C and incubation periods of up to 48 hr did not affect the viability of C. 
pneumoniae. One hundred percent of the C. pneumoniae EB were infective after a 
1 hr incubation at 35°C, whereas 90%, 50% and 40% respectively survived after 
incubations of 8, 24 and 48 hr. The viability of C. pneumoniae was uneffected 
within the investigated range of Ca 2 + and Mg2 + ion concentration in the medium. 
The presence of 10% foetal calf serum (FCSI in the incubation medium had a 
stabilizing effect on the viability of C. pneumoniae. This effect became more 
pronounced as the incubation period increased. 
INTRODUCTION 
Chlamydia pneumoniae, previously known as Chlamydia psittaci TWAR [5], is an 
important cause of respiratory complaints in adults [111. C. pneumoniae epidemics 
have been observed both in local and in nation-wide communities [8, 13]. Since the 
initial isolation of C. pneumoniae from patient material is tedious, the diagnosis is 
generally based on the presence of acute phase antibodies [6]. In contrast to C. 
trachomatis which requires mucous membrane to mucous membrane contact for 
its transmission, C. pneumoniae is most probably transmitted via aerosols. C. 
pneumoniae infections are not season dependent [15]. The microbe has to be able 
to withstand physical changes in its environment in order to survive outside its 
host. 
Changes in pH, salt concentration, temperature, concentrations of Ca 2 + and 
Mg 2+ ions were investigated in order to establish the limit(s) to which these 
parameters affected the infectivity of C. pneumoniae EB on HL cells. 
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MATERIALS AIIID METHODS 
Chlamydia strain and antigen purification 
C. pneumoniae (strain TW-1831 was propagated in Hl cells as described by Cles 
& Stamm [3]. Briefly, HL cells were seeded in 25 em' tissue culture flasks (Costar, 
Cambridge, Ma.). After the cells had grown to a confluent monolayer, they were 
preincubated for 15 min in Hanks Balanced Salt Solution (HBSS, Flow, Irvine, 
Scotland) containing 15 pg/ml DEAE dextran (Sigma, USA). The monolayer was 
subsequently inoculated with C. pneumoniae. After centrifugation for 1 hr at 1200 
x g, the medium was replaced by Eagles modification of Minimal Essential Medium 
I EM EM, Flow) containing 10% FCS, 2 mM glutamine (Flow), 1% Vitamin (Flow), 
18 pg/ml gentamicin, 23 pg/ml vancomycin, 2.5 pg/ml amphotericin Band 1 pg/ml 
cycloheximide (Sigma) (EM EMS). Cells containing C. pneumoniae were sonicated 
following a 72 hr incubation at 37°C in an atmosphere containing 5% C02 . C. 
pneumoniae EB were partially purified by differential centrifugation at 500 x g for 
10 min and at 30000 x g for 30 min. After centrifugation, EB were suspended in 
SPG comprising 20 mM phosphate buffer containing 0.2 M sucrose (Merck, 
Germany), 49 mM glutamine (Sigma, USA), 10% FCS (Hyclone Lab. Utah), 18 
pg/ml gentamicin, 23 pg/ml vancomycin and 2.5 pg/ml amphotericin B at a 
concentration of 2x1 0 8 inclusion forming units (IFUJ/ml and stored at -80°C. 
Culturing and staining 
Tissue culture plates with 24 wells (Greiner, Solingen, Germany) containing 
confluent monolayer of HL cells for C. pneumoniae culture were pretreated with 
HBBS containing DEAE dextran as described above. The monolayer was then 
inoculated with C. pneumoniae and centrifuged for 1 hr at 1200 x g and incubated 
in EM EMS at 37°C in an atmosphere containing 5% C0 2 for 72 hr after which the 
infected monolayer was fixed with 96% ethanol. C. pneumoniae inclusions were 
stained with anti-C. pneumoniae monoclonal antibody (Washington Research 
Foundation, Seattle) and fluorescein isothiocyanate-labeled goat anti-mouse 
Immunoglobulins (Central Laboratory of the Netherlands Red Cross Blood 
Transfusion Service, Amsterdam, The Netherlands), in 0.003% Evans Blue (Sigma). 
Inclusions were counted at a magnification of x320 using a Leitz Ortholux 
fluorescent microscope. 
Incubation with variations in pH 
C. pneumoniae was diluted to a concentration of 2 x 105 IFU/ml with SPG at pH 
from 4-10 increasing in steps of 0.5 units. After incubation for 1 ,4,8,24 and 48 hr 
at 22°C, a 0.2 ml sample was withdrawn from each tube into 1.8 ml EMEMS. Prior 
to infecting HL cells, any deviation from pH of 7.5 was corrected by bubbling air 
or C0 2 • Tissue culture plates with 24 wells containing mono layers of HL cells were 
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inoculated in triplicate with 0.4 ml samples. As positive controls, 4 wells were 
inoculated with a 0.4 ml suspension of C. pneumoniae in EMEMS. The 
concentration of C. pneumoniae EB in the control tubes was identical to the end-
dilution in the tubes which were incubated at varying pH. The number of IFU/well 
in the positive control was set at 100%. 
Incubation with variations in NaCI concentration 
C. pneumoniae was diluted to a concentration of 2 x 1 0 4 1FU/ml with distilled water 
containing 10% FCS at NaCI concentrations ranging from 15.4 mM to 400 mM 
increasing in steps of 40 mM. After different incubation periods (as described 
above for variations in pH). 1.6 ml distilled water containing 10% FCS and NaCI 
were added to 1 ml of the sample such that the final concentration of NaCI in each 
tube was physiological (154 mMI. The subsequent steps were the same as those 
described above for variations in pH. 
Incubation with variations in temperature 
C. pneumoniae was diluted with SPG to a concentration of 2 x 105 IFU/ml. 
Incubations were carried out at temperatures ranging from 0°C to 45°C in steps 
of 5° C. Alter different incubation periods (as described above variations in pH), 0.2 
ml sample from each tube was withdrawn into 1.8 ml EMEMS. The subsequent 
steps were the same as those described for variations in pH. 
Effect(s) of SPG and FCS 
i)SPG. C. pneumoniae was diluted with PBS to a concentration of 2 x 105 IFU/ml 
at pH 4.5, 7.0 and 9.0 instead of SPG at similar pH values. Incubations were 
carried out at 5°C, 25°C and 45°C. The subsequent steps were the same as those 
described above for variations in pH. 
ii)FCS. C. pneumoniae was diluted with distilled water to a concentration of 2 x 104 
IFU/ml and at NaCI concentrations of 80 mM, 154 mM, 240 mM, 320 mM and 400 
mM instead of 10% FCS in distilled water containing similar NaCI concentrations. 
Incubation was carried out at 22 °C. The subsequent steps were the same as those 
described above for variations in NaCI concentration. 
Incubation with variations in the concentration of Ca 2 + and Mg2 + ions 
C. pneumoniae was diluted to a concentration of 2 x 1 0 4 1FU/ml with distilled water 
containing 10% FCS, 154 mM NaCI at CaCI, concentrations from 0.346 mM to 4 
mM at increasing steps of 0.5 mM or MgCI 2 at concentrations from 0 mM to 2.5 
mM at increasing steps of 0.5 mM. After different incubation periods (as described 
above for variations in pHI. a 1 ml sample was adjusted to physiological Ca'+ and 
Mg'+ concentrations of 2.5 mM and 1 mM repectively, with 0.46 ml of EMEMS 
containing Ca'+ and Mg'+, after which HL cells were infected. The subsequent 
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steps were the same as those described above for variations in pH. 
Statistical methods 
Variations within a single experiment were determined by calculating the Standard 
Error of the Mean (SEMI. 
RESULTS 
Variations in pH 
One hundred percent of the C. pneumoniae EB survived after incubation for 24 hr 
at 22°C in SPG medium at pH range 5 to 8 (Fig. 1 ). After 48 hr incubation at pH 
range 5 to 8, the viability of C. pneumoniae decreased to about 65%. At pH lower 
than 5 or higher than 8, there was a strong decline in the number of infectious 
organisms (Fig. 1 ). The survival of C. pneumoniae incubated for 4 hr at 22°C in 
PBS at different pH was similar to the survival in SPG medium. Incubations for 
longer periods showed that SPG had a stabilizing effect on the viability of C. 
pneumoniae. After incubations for 8, 24 and 48 hr in PBS at pH 7.0, survivals of 
respectively 78.2%, 29.1% and 0% were observed. 
4 5 6 7 8 9 10 
pH 
Figure 1 
Survival of C. pneumoniae in SPG with changing pH and incubation periods at 22°C. Percentage 
survival after incubations of 1 hr (-o-); 4 hr i-+-J: 8 hr (-.t.-); 24 hr (-Ill-) and 48 hr (-v-) at pH from 
4.0 to 10.0 (increasing in steps of 0.5 units). n=9; SEM s 15% (results not shown). 
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Variations in NaCI concentration 
The viability of C. pneumoniae in medium containing 10% FCS was affected only 
at NaCI concentrations of lower than 80 mM (Fig. 2). After longer incubation 
periods (24 and 48 hr), a gradual decline in the viability was observed over the 
whole range of NaCI concentrations that were tested. The infectivity of C. 
pneumoniae was stabilized by FCS. The effect of FCS on the survival of C. 
pneumoniae EB increased as the incubation periods increased. After incubations of 
8, 24 and 48 hr in distilled water at physiological NaCI concentration without FCS, 
survivals of respectively 54.7%, 16.9% and 0% were observed. 
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Figure 2 
Survival of C. pneumoniae in distilled water containing 10% FCS with changing NaCI concentration 
and incubation periods at 22°C. Percentage survival after incubations of 1 hr (-o-); 4 hr (-+-); 8 
hr (- ... -); 24 hr (-•-) and 48 hr (-v-) at NaCI concentrations from 15.4 mM to 400 mM (increasing 
in steps of 40 mM). n=9; SEM :S 20% (results not shown). 
Variations in temperature 
No adverse effect on the viability of C. pneumoniae in SPG medium was observed 
after incubation at temperatures between 0°C and 20°C (Fig. 3). The viability of 
C. pneumoniae decreased at temperatures above 20°C and this adverse effect of 
increasing temperature on the survival increased as the incubation periods 
increased. The stabilizing effect of SPG on the survival of C. pneumoniae increased 
as the temperature and/or the incubation period increased. Incubation in PBS at 
25°C for 8, 24 and 48 hr resulted in survivals of respectively 78.2, 29.1 and 0%. 
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Figure 3 Survival of C. pneumoniae in SPG with changing temperature and incubation periods. 
Percentage survival after incubations of 1 hr (-o-); 4 hr (-+-); 8 hr (-.t..-); 24 hr (-11-) and 48 hr (-.,.-) 
at temperatures from 0°C to 45°C (increasing in steps of 5° C). n=9; 
SEM ::5 25% (results not shown). 
Variations in the concentration of Ca2 + and Mg2 + ions 
Variations of Ca2 + ion concentration from 0.346 mM to 4 mM or Mg 2 + ion 
concentration from 0 mM to 2.5 mM at pH 7.5 and physiological NaCI 
concentration had no effect on the survival of C. pneumoniae (data not shown). 
DISCUSSION 
The results of this study showed that the survival of C. pneumoniae in SPG medium 
declined rapidly at pH lower than 5 or at pH higher than 8. Narita et al [12] 
observed a decrease in the turbidity when C. psittaci EB were exposed to an 
alkaline pH. These authors also demonstrated that the loss in the turbidity was 
coupled with the loss of EB contents. It is likely that the loss of cell contents 
results in the death of the organism. However, these authors did not check the 
viability. It was demonstrated that the major outer membrane protein IMOMPI is 
acidic [1]. Therefore, it is possible that exposure to an alkaline pH causes 
irreversible changes in the structure of MOMP. A possible explanation for the loss 
of viability at pH lower than 5 may be that the reduction of disulphide bonds 
between cysteine-rich proteins in the outer membrane of Chlamydiae, results in the 
loss of rigidity of EB. 
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C. pneumoniae EB were well able to withstand the changes in the osmolarity 
of the medium. In medium containing FCS, the viability was observed to be 
affected only at NaCI concentrations of lower than 80 mM in the range 15.4 mM 
to 400 mM that was tested. C. pneumoniae EB are probably resistant to hypertonic 
media since they are metabolically inactive. loss of water to the hypertonic 
environment probably has no effect on the membrane proteins which are 
responsible for the adhesion and invagination of EB to the host cells. In that case, 
the infectivity of EB remains unimpaired. Rigidity of EB may be lost due to water-
uptake in hypotonic media. 
The survival of C. pneumoniae in SPG medium was observed to be 100% 
after incubation for 48 hr at temperatures of between 5°C and 20°C. The survival 
was observed to be 80% after incubation for 48 hr at 25°C. Kuo et al [9] observed 
a significant decline in the viability of C. pneumoniae strain AR-39 in SPG medium 
after incubation at 22°C. No living organisms were observed after 48 hr. As 
compared with the results of this study, in their study, the survival declined rapidly 
also after incubation at 4°C. There are several possible explanations for these 
discrepancies. Kuo et al cultured on He La 229 cells, whereas, later it was reported 
[3, 1 OJ that HL cells were more suitable than Hela 229 cells for culturing C. 
pneumoniae. Kuo et al used C. pneumoniae strain AR-39, whereas in this study we 
used strain TW-183. Although it is true that both these strains are identical with 
respect to DNA-DNA hybridization and restriction endonuclease analyses [6]. it is 
possible that both strains may have background anomalies with respect to their 
adaption in vitro and growth on cell lines. It is well known that the initial in v'1tro 
isolation of C. pneumoniae from patient material is tedious. However, subsequent 
propagation after the first few passages is relatively easier [13]. A higher efficiency 
in the culturing of the TW-183 strain used in the present study could have been 
due to adaptation to laboratory conditions. 
The orientiation of the dipole moments of phospholipids in the membrane is 
influenced by the presence of divalent cations in the medium. Alterations in the 
dipole moments may indirectly cause conformational changes in the membrane 
lipids. The activity of the membrane-bound proteins may be regulated in this way 
[14]. The infectivity of C. pneumoniae EB was not affected by changes in the 
concentrations of either the Ca 2 + or the Mg 2 + ions. Up to 3 successive freeze-
thawings of C. pneumoniae did not result in any decline in the number of IFU. Other 
authors [9] reported a decline of 11% in the number of IFU after freeze-thawing. 
The survival of C. pneumoniae was considerably affected not only by SPG 
but also by the FCS contained in SPG. The stabilizing effect on the integrity of EB 
became greater as the incubation period increased. The SPG medium was originally 
used since it had shown a benificial effect on the survival of Rickettsiae outside its 
host [2]. Since its introduction in 1969 for isolating C. trachoma/is [4L SPG 
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medium has been generally accepted as Chlamydia 'storage' medium. The role 
played by various constituents of SPG medium on the stability of Chlamydia were 
never investigated further. 
Survival of C. pneumoniae outside host cells is limited. Transmission of C. 
pneumoniae between various members of the same family [16] supports a direct 
host to host transmission, although transmission via fomites cannot be totally 
excluded. A recent report also supports the possibility of spread by droplet 
aerosolization [7]. 
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SUMMARY 
The survival of Chlamydia pneumoniae in aerosols was investigated using a 
chamber with a capacity of 114.5 l. We injected 5x107 inclusion forming units 
(IFUI of C. pneumoniae in aerosols with a droplet-size of 3-5 pm. Samples were 
taken after 0.5 min and every min thereafter. The survival of C. pneumoniae was 
measured at four temperatures (8.5, 15, 25 and 35°CI and at three different 
relative humidities (RH) of 5, 50 and 95% for each temperature. The survival of 
Streptococcus pneumoniae, Streptococcus faecalis, Klebsiella pneumoniae, 
Chlamydia trachomatis LGV2 and cytomegalovirus were also determined at 25°C 
and 95% RH and compared with that of C. pneumoniae. At the mentioned 
temperatures and RH, a rapid decrease of C. pneumoniae IFU was observed in the 
first 30 s. After this the decrease in the number of IFU was more gradual. The 
survival of C. pneumoniae in aerosols was optimum at 15-25°C and 95% RH; it 
was good compared with that of other microorganisms. A lower death rate was 
observed only inS. faecalis. In C. trachomatis, death rate during the first 30 s was 
higher than that in C. pneumoniae (85% and 53.3% respectively). After the first 
30 s, the death rates in the two organosms were identical. It was concluded that 
transmission of C. pneumoniae via aerosols was possible. There is probably a direct 
transmission from person to person taking into account the relatively short survival 
period of C. pneumoniae in aerosols. 
INTRODUCTION 
Transmission of microorganisms which cause respiratory infections probably occurs 
via an airborne route. In contrast to transport over long distances, host-to-host 
transmission is a relatively rapid process which occurs via sneezing and coughing 
and which is accompanied by transmission of microorganisms in small droplets of 
3-10 pm, the so-called aerosols. 
During the aerial passage, the survival of microorganisms in aerosols depends 
on five different factors: relative humidity {RH). temperature, level of oxygen, 
presence of UV radiation and constituents of the aerosol and air (12, 16). The 
degree to which these factors influence the survival of microorganisms in aerosols 
depends strongly on the type of microorganism and the time it has to spend in the 
aerosol. In general, the following rules apply. Gram-negative bacteria survive the 
best at low temperatures and RH (4,5). Gram-positive bacteria survive better at low 
temperatures and high RH (5,6). In almost all cases, gram-positive bacteria survive 
better and longer than gram-negative bacteria in aerosols. The sensitivity of gram-
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negative bacteria to oxygen depends on the species. Viruses with membrane lipids 
are more stable in aerosols than are viruses without membrane lipids {5). Viruses 
which possess lipids survive the best at RH below 50%, whereas viruses which do 
not possess lipids are most stable at RH above 50% (6). 
C. pneumoniae is a recently reported microorganism which can cause 
respiratory infections varying in seriousness from bronchitis to atypical pneumonia 
(10). Although, no proof has yet been provided, it is assumed that C. pneumoniae 
is transmitted via aerosols. A possible indication for such a mode of transmission 
was provided by the accidental infection of laboratory personnel with C. 
pneumoniae (14). Transmission must progress particularly efficient because 50-
60% of the European and North American population experience an infection with 
C. pneumoniae at the age of 5 to 15 years 1101. 
In the present study the survival of C. pneumoniae elementary bodies (EBs) 
in air was determined at different temperatures and relative humidity in an aerosol 
chamber to obtain further insight into its mode of transmission. A possible 
relationship between climate/seasons and the efficiency of transmission could thus 
be investigated. In order to make the acceptable assumption that infection with C. 
pneumoniae occurs via the airborne route, survival of other respiratory 
microorganisms in the same aerosol chamber was also determined. 
Transmission of the urogenital pathogen Chlamydia trachomatis LGV 2 
requires contact between mucous membranes. If transmission of C. pneumoniae 
occurs via an airborne route, an adaptation of C. pneumoniae to this mode of 
transmission is likely and differences in the survival rate in aerosols between C. 
trachomatis LGV2 and C. pneumoniae can be expected. Differences in the survival 
of C. trachoma tis LGV 2 and C. pneumoniae were determined by comparing the 
infectivity decrease of both microorganisms in aerosols. 
MATERIAlS AND METHODS 
Microorganisms and antigen purification. Chlamydia pneumoniae (strain TW-1831 
was propagated in HL cells as described by Cles and Stamm (3). HL cells were 
seeded in 75 cm2 tissue culture flasks (Costar, Cambridge, Mass.). After the cells 
had grown to a confluent monolayer, they were pre-incubated for 15 min in Hank's 
balanced salt solution (HBSSI supplemented with 15 119/ml DEAE dextran (Sigma, 
Chem. Camp., StLouis, Miss.). The monolayer was subsequently inoculated with 
C. pneumoniae. After centrifugation at 1200 x g for 1 h, the medium was replaced 
by Eagle's modification of minimal essential medium (Flow Laboratories, Irvine, 
Scotland) containing 10% fetal calf serum (FCS; Hyclone Laboratories, Inc., Logan, 
Utah). 2 mM glutamine (Flow). 1% vitamins (Flow). 18 Jlg/ml gentamicin, 23 119/ml 
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vancomycin, 2.5 pg/ml amphotericin B and 1 pg of cycloheximide (Sigma) per ml 
(EMEMS). Following incubation at 37°C for 72 h in an atmosphere containing 5% 
C02 , C. pneumoniae containing cells were sonicated and partially purified by 
differential centrifugation at 500 x g for 10 min and at 30000 x g for 30 min. The 
30000 x g pellet was homogenized in SPG comprising 20 mM phosphate buffer 
containing 0.2 M sucrose (Merck, Darmstadt, Germany), 49 mM glutamine (Sigma), 
10% FCS, 18 pg/ml gentamicin, 23 pg/ml vancomycin and 2.5 pg/ml amphotericin 
B and centrifuged at 53000 x g for 1 h through a 30% urografin solution (3.9 
g/1 00 ml sodium amidotrizoate, 26 g/1 00 ml meglumine amidotrizoate, 146 
mg/1 00 ml iodine). Chlamydiae in the resulting pellet were washed once with 
phosphate-buffered saline (PBS, pH 7,4 I and stored in SPG at -80 °C until use. 
Chlamydia trachoma tis LGV2 (strain 343/Bu) was propagated in McCoy cells. 
Culture and purification of C. trachomatis were identical to those described for C. 
pneumoniae. We chose C. trachomatis so that we could compare two organisms 
that belong to the same genus but cause different infections. 
Streptococcus faecafis, Klebsiella pneumoniae and Streptococcus 
pneumoniae were isolated from throats of patients with respiratory disorders. Pure 
cultures of the bacteria were established in Todd-Hewitt bouillon (Oxoid, 
Basingstoke, United Kingdom) by culturing for 16 h and were then stored in Todd-
Hewitt bouillon supplemented with 10% glycerol (Merck) at -80°C till use. S. 
faecalis was included because its survival in aerosols is known to be good (13). K. 
pneumoniae and S. pneumoniae were included as examples of a gram-negative and 
a gram-positive microorganism which may cause infections in the respiratory tract. 
Cytomegalovirus (CMV, Strain Kerr) was cultured in MRC-5 cells (Flow). The 
cells were seeded in 75 em' tissue culture flasks (Costar) and were grown to a 
confluent monolayer. The medium was then removed and the cells were inoculated 
with 105-106 plaque forming units (PFUI of CMV in Dulbecco's modification of 
minimal essential medium supplemented with 2 mM glutamine, 2.5% FCS, 1% 
amino acids and 18 pg/ml gentamicin (DMEMS) and incubated at 37"C for 2 h 
under an atmosphere containing 5% C02 . After incubation, the free virus was 
rinsed away and the cells were incubated in DMEMS at 37°C for 5 days under an 
atmosphere containing 5% C02 . Virus containing cells were subsequently sonicated 
and the virus was partially purified by centrifugation at 1500 x g for 10 min. The 
CMV containing supernatant was stored at -80 °C until use. Cytomegalovirus was 
included as an example of a virus which may cause infections in the respiratory 
tract. 
Culture and staining. Tissue culture plates with 24 wells (Greiner, Solingen, 
Germany) containing Hl cells tor C. pneumoniae culture or McCoy cells for C. 
trachomatis LGV2 culture were treated with Hank's balanced salt solution 
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containing DEAE as described above. Monolayers were inoculated with Chlamydiae, 
centrifuged at 1200 x g for 1 h and incubated in EMEMS for 72 h at 37°C in an 
atmosphere containing 5% C02 • After incubation, the infected monolayer was fixed 
with 96% ethanol (Merck). C. trachomatis lGV2 inclusions were stained with anti-
C. trachomatis monoclonal antibody (Microtrak, Syva CO., Palo Alto, Calf.). C. 
pneumoniae was stained using anti-C. pneumoniae monoclonal antibody 
(Washington Research Foundation, Seattle, Wash.) and fluorescein isothiocyanate-
labeled goat anti-mouse immunoglobulins (Central Laboratory of the Netherlands 
Red Cross Blood Transfusion Service, Amsterdam, The Netherlands) in 0.003% 
Evans blue (Sigma). Inclusions were counted with a Leitz Ortholux fluorescent 
microscope. 
S. faecalis and K. pneumoniae were cultured in Todd-Hewitt agar (Oxoid) at 
37 °C for 16 h. S. pneumoniae was cultured on blood agar (Oxoid) at 37 °C for 
16 h in an atmosphere containing 5% CO,. 
Tissue culture plates with 24 wells (Greiner) containing MRC-5 cells were 
inoculated with CMV and incubated at 37°C in an atmosphere containing 5% C02 • 
After 1 h the medium was substituted with 1 ml of two-fold strenght Basal Medium 
(Eagle)-without phenol red (Dileo Laboratories, Detroit, Michl. diluted twofold with 
1.2% Seakem-ME agarose (FMC Bioproducts, Rockland, Maine) in distilled water, 
yielding full strenght medium containing 0.6% agarose. After incubation at 37°C 
for 10 to 14 days under an atmosphere containing 5% C0 2 , the cells were fixed by 
incubation with 10% formalin in PBS for 24 h. After fixing, the agar layer was 
removed and the cells were stained for 1 min with 1% methylene blue in distilled 
water. After destaining with distilled water, the plaques were counted at a 
magnification of x100. 
Aerosol Chamber. The aerosol chamber comprised a stainless steel cylindrical 
container with a capacity of 114.5 Liters (Fig. 1 ). The temperature in the chamber 
could be varied from 8. 5°C to 70°C by altering the temperature of the surrounding 
water jacket. which was connected to a water bath with a temperature regulator. 
The RH could be varied either by using water vapor (increase in RH) or by pumping 
air which had been passed through silica column (decrease in RH) into the chamber. 
Eventual over- or underpressure was compensated for via a hydrophobic, 
autoclavable 0.45 pm or 0.22 pm pore-size filter (Millipore lntertech, Bedford, MA). 
The RH in the chamber was measured with a MC-2 humidity probe (Panametrics, 
Waltham, MA.), and the temperature was measured with a PT-100 electrode. Both 
probes were autoclavable. The temperature and RH could be read on the home 
made digital display. A FK-8 aerosol gun was used to generate aerosols (7). The 
pressure 15 kg/cm 2 ) that was required for injection was obtained from a nitrogen 
(N2 ) gas cylinder. At this pressure of injection, a 1 ml sample was dispersed in 4 
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s into aerosols with a droplet-size of 3-5 Jim. Samples were obtained via a stainless 
steel capillary impinger with a diameter of 1 mm. The rate of sampling was 10 
L/min, and the size of the sample was 5 liters. The content of the aerosol chamber 
was kept homogeneous using a ventilator with four fins with a diameter of 5.5 em 
and a speed of 3000 rpm. The infected compartment of the aerosol chamber was 
a closed system which could be autoclaved. 
In each experiment, 1 ml PBS supplemented with 10% FCS containing either 
5x1 0 7 inclusion forming units (IFU) of Chlamydiae EBs or 1 x1 0 8 to 5x1 08 CFU of 
S. faecalis, S pneumoniae or K. pneumoniae obtained from a 16-h culture was 
injected. For CMV, 1,4x107 PFU contained in 1 ml DMEMS was injected. The 
sampling medium was the same as that used for injection and consisted of PBS 
supplemented with 10% FCS. The protein concentration of this medium (0.35 
g/100 ml) is similar to the protein concentration found in saliva. 
In separate experiments, the physical fallout was measured over 5.5 min for 
every temperature and RH by spraying 5x10 7 cpm 87Ga labeled gallium citrate in 1 
ml PBS containing 10% FCS. A 5-liter sample was taken after 0.5, 1.5, 2.5, 3.5, 
4.5 and 5.5 min. The total number of counts per minute in the samples obtained 
at different times was subsequently set at 100%. In performing the control 
experiments, with 67Ga, it was observed that the maximum recovery at all RH 
tested, was 2% of the total that was converted to aerosol. The physical fallout 
measured over the 5.5-min period appeared to be negligible. Theoretically, the 
physical fallout is the highest at high RH because droplets can form on the wall of 
the aerosol chamber. Several experiments for determining this fallout were repeated 
with 1251-labeled C. pneumoniae EBs (9). 1251-labeled C. pneumoniae EBs (5x10 7 1FU) 
were injected at 8.5, 15, 25 and 35°C and 95% RH. Subsequently, the physical 
fallout (decrease in the number of counts per minute) and the survival of C. 
pneumoniae under the tested conditions were determined. The physical fallout 
measured during 5.5 min was negligible, whereas the decrease in the number of 
infectious EBs was comparable to that of unlabeled C. pneumoniae EBs under the 
same conditions. On the basis of this information, we decided to express the 
decrease in the number of infectious organisms in aerosols as a ratio viable 
microorganisms {mo)/67Ga. 
Prior to spraying the microorganisms in the aerosol chamber, we tested 
whether they could withstand the injection pressure of 5 kg/em' and the high air 
speeds that are reached during sampling. For this purpose, prior to spraying, the 
microorganisms were cultured as described above. 
The microorganisms were then injected directly into the sampling medium 
using the aerosol gun and cultured again. To check their survival during sampling, 
we suspended the microorganisms in sample medium and cultured as them as 
described 
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Figure 1. Schematic diagram of the aerosol chamber. 1. Water vapor generator. 2. Temperature and 
RH meter. 3. Pump. 4. Silica column. 5. Filter (0.22 pm or 0.45 pm). 6. Aerosol gun. 7. 
Temperature and RH probes. 8. Capillary impinger. 9. Water~jacket. 10. Nitrogen cylinder. 11. 
Ventilator. 
above. Subsequently, 5 L of air was sucked via the capillary impinger through the 
sampling medium containing the microorganisms and the microorganisms were 
cultured again. All the microorganisms that were used in this study appeared to 
withstand the injection-pressure as well as the air speeds during sampling. 
All experiments and checks were performed at least in duplicate. 
Statistic analysis. Differences between survival of C. pneumoniae at different 
temperatures and RH and those of C. pneumoniae and other microorganisms tested 
were analysed by using multiple linear regression analysis after log transformation. 
The starting point of analysis is from 0.5 minutes after spraying the organisms. 
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RESULTS 
The survival of C. pneumoniae during 5.5 min at different temperatures and RH are 
depicted in Fig. 2. 
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Figure 2. The survival of Chlamydia pneumoniae at different temperatures and relative humidity. The 
survival at 8.5°C (A), 15°C (8), 25°C (C) and 35°C (D) is expressed as a ratio of viable 
microorganisms/87 Ga. Survival of C. pneumoniae was measured during 5.5 min at 5% RH (-+-), 
50% RH (-II-) and 95% RH (-v-). Error bars indicate the variation in the measurements. In the cases 
where the error bars are not visible, the variation was so small that they are beyond the range of 
scale that was used. 
An initial rapid inactivation of infectious C. pneumoniae EBs during the first 0.5 min 
which was followed by a more gradual decrease in death rate during the next 5 
min. It was also observed that the loss of infectious EBs was the lowest at high 
RH. The survival at 95% RH was significant higher than that observed at 5% or 
50% RH (P< 0.0001 ). The best temperature for the survival of C. pneumoniae EBs 
in aerosols was between 15°C and 25°C (Figs. 28 and 2C). However, the survival 
at 5°C did not differ significantly from that at 15°C or 25°C. At 35 °C only, the 
survival was lower than the survival at other temperatures (P< 0.001 ). The rate 
of survival at 50% RH was observed to be dependent on the temperature, The 
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survival of C. pneumoniae EBs at 8.5°C and 50% RH (Fig. 2A), was almost 
identical to that at 95% RH. The survival at 15°C and 25°C and 50% RH was 
identical to that at 5% RH, but lower than the survival at 95% RH (Figs. 28 and 
2C). Hardly any infectious EBs were observed at 35°C after 0.5 min when 
measured at 50% RH. The percentage survival was then lower than that observed 
at 5% and 95% RH (Fig. 2D). 
The survival of C. pneumoniae in aerosols was compared with that of other 
microorganisms at 25 °C and 95% RH. A comparison of the results is depicted in 
Fig. 3. It can be seen that under the tested conditions, only S. faeca/is in aerosols 
survived better than C. pneumoniae, but the difference was not statistically 
significant. The survival of the respiratory tract pathogen K. pneumoniae was 
slightly lower (P = 0.062). whereas the survival of the pathogens S. pneumoniae 
(P< 0.0001) and CMV {P< 0.0001) was clearly lower than that of C. pneumoniae. 
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Figure 3. The survival of different microorganisms at 25°C and 95% RH. The survival is expressed 
as a ratio of viable mo: 67Ga. The survival during 5.5 min was measured for S. feacaHs (-0-), C. 
pneumoniae {-A-), K. pneumoniae (-Y-), C. trachomatis LGV2 {-+-), Cytomegalovirus(-111-) and S. 
pneumoniae (-D-). Error bars indicate the variation in the measurements. 
The high inactivation of S. pneumoniae during the first 0.5 min was noteworthy. 
Thereafter, during the period of measurement, there was no further decrease in the 
number of S. pneumoniae CFU. 
The decrease in the number of infectious C. trachomatis LGV 2 IFU in aerosols 
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during the first 0.5 min was much higher than that of C. pneumoniae IFU (85.0% 
and 53.4% respectively). After the first 0.5 min, death rates in both 
microorganisms were identical 112% per min). Overall there was a significant 
difference in survival between the organisms 
(P< 0.001). 
DISCUSSION 
The percent survival of C. pneumoniae in aerosols was highest at high RH and at 
temperatures between 15°C and 25°C. Dehydration appeared to be an important 
factor in the inactivation of C. pneumoniae, whereas extreme temperatures had a 
more limited influence on the survival. Inactivation was highest immediately after 
injection of the aerosols. This phenomenon was also observed after spraying of 
other microorganisms 117,20). The vapor pressure ofthe aerosol was in equilibrium 
with that of the surrounding. At low RH, the water in the aerosol immediately 
evaporated into the surroundings. Increases or decreases in temperature caused 
higher and lower evaporation rates, respectively. Several membrane reactions may 
occur depending on the composition of the membrane and presence or absence of 
a cell wall. Transition of lipids from the liquid/crystalline state to the gel state is a 
possible inactivation mechanism. The probability of such a phase transition 
increases with decreasing temperature and RH (8). Since a considerable proportion 
of the membrane lipids of Chlamydiae consist of unsaturated fatty acids (15). it is 
plausible that the temperature at which the transition to gel state occurs lies 
between 0 and 1 0°C. This may possibly explain the lower survival of C. 
pneumoniae in aerosols at 8.5°C and 95% RH as compared with the survival at 15-
250C and 95% RH. 
Another inactivation mechanism is the occurrence of Maillard reactions at 
low to moderate RH (0-50%). The probability of these reactions, which require low 
activation energy, increases with increasing temperature (5). Such reactions occur 
either between lipids and proteins or between proteins and proteins and result in 
the removal of water. Inactivation of the proteins involved in anchoring and 
invagination of C. pneumoniae to the host cell may then occur, resulting in a 
decreased infectivity of C. pneumoniae in aerosols. Inactivation of proteins in the 
Maillard reaction may be an explanation for the low survival of C. pneumoniae EBs 
at 35 °C, especially at 5% and 50 %RH. 
Damage to the outer membrane of gram-negative bacter'1a is another 
mechanism by which microorganisms can be inactivated during spraying in 
aerosols. As such, after spraying in 75% RH, 80% of Escherichia coli MRE 160 
were susceptible to lysozyme action, indicating membrane damage (11 ). It was also 
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reported that in bacteria and viruses inactivation at high RH was the result of 
surface inactivation due to the (partial) removal of proteins from the outer 
membrane (2, 19). In contrast with bacteria, C. pneumoniae EBs, because they are 
metabolically inactive, possess no repair mechanisms so that any eventual damage 
to the outer membrane cannot be restored. Because the survival of C. pneumoniae 
was the highest at high RH and because the membrane integrity of C. pneumoniae 
EBs depends on disulfide bridges between proteins in the outer membrane (1), in 
contrast with that of other gram-negative bacteria, it seems likely that the integrity 
of outer membrane proteins of C. pneumoniae is higher than that of other gram-
negative bacteria. This limits the loss of outer membrane proteins during spraying 
which has a beneficial effect on the survival at high RH. 
At low RH, two other mechanisms, namely the toxic effect of salts or amino 
acids in the aerosol from which the water has evaporated ( 19) and inactivation due 
to withdrawal of structural water molecules play a role. Since C. pneumoniae EBs 
are resistant to high salt concentrations in liquid media (18), it is possible that, at 
low RH, inactivation occurs via the withdrawal of structural water molecules. 
The results in Fig. 3 show that the survival of C. pneumoniae in aerosols, 
u_nder the conditions tested, is better than that of most other pathogens. Only S 
faecalis, a bacterium known to survive well in aerosols at 95 %RH ( 13), had a 
higher percent survival. Compared with pathogens that are likely to be transmitted 
by aerosols, i.e., K. pneumoniae, S. pneumoniae and CMV, C. pneumoniae showed 
better survival. Although it can not be excluded that another order of survival 
percentages between the organisms would be observed under different test 
conditions, transmission of infection with C. pneumoniae via the airborne route 
seems probable. The difference between the uropathogenic serovar C. trachomatis 
and the respiratory pathogen C. pneumoniae was noteworthy. C. pneumoniae was 
more resistant to the stress which occurred in the aerosol during the first 0.5 min 
after spraying. It is possible that the tertiary structure of one or more proteins in the 
outer membrane of C. pneumoniae is more resistant to dehydration and/or 
mechanical damage during the first 0.5 min. 
When only the survival of C. pneumoniae in aerosols is taken into account, 
transmission of this pathogen occurs most efficiently when the temperature is 
between 15°C and 25°C and the RH is high. However, a number of other variables 
such as UV radiation, host resistance and minimal infectious dose should also be 
taken into consideration before the results are extrapolated to the real-world 
situation. 
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SUMMARY 
The effects of suspension media and rate of freezing on the survival of Chlamydia 
trachomatis LGV2 and Chlamydia pneumoniae after lyophilization were assessed. 
The highest loss in infectious elementary bodies IEBs) occurred during 
lyophilization. The survival was higher after freezing at a rate of 1 °C min·' and 
lyophilization than that after rapid freezing at -70°C or -196 °C. The recovery I± 
5%) was higher when fetal calf serum (FCS) containing glucose, saccharose or 
lactose was used as lyophilization media than that (0.5% - 3%) when yolk-sac, 
skimmed milk or phosphate buffer containing sucrose, glutamin and 10% FCS 
ISPG) were used. After lyophilization, the survival was not affected in the tested 
range from 104 to 5x1 0 6 inclusion forming units IIFU) mr1 prior to freezing. After 
storage for 4 months at 4°C, the numbers of IFU of both Chlamydia serovars that 
were recovered were identical to the numbers of IFU immediately after 
lyophilization. It was concluded that chlamydias can be stored and transported in 
lyophilized form. However, a loss of 95% in infectious EBs should be taken into 
account. 
INTRODUCTION 
Lyophilization is the most suitable method for preserving bacteria, viruses, yeasts 
and fungi for culture collections, provided that the micro-organisms are able to 
withstand this procedure (Lapage eta!. 1970a). In principle, the method is based 
on a process in which cell suspensions are first frozen and then ca 95% of the 
water in the suspension is sublimated. After this, in certain cases, all but the last 
1-2% of the residual water is gradually removed under vacuum. This method is very 
acceptable because most of the clinically interesting micro-organisms may be 
lyophilised without any significant loss in their viability. Moreover, because 
lyophilized micro-organisms may be stored for prolonged periods, it costs little to 
store them and no special precautions are required for transportation. Possible 
disadvantages of lyophilization may be damage to DNA (Ashwood-Smith and Grant 
1976], to the cell wall (Ohtomo eta/. 1988) or to lipopolysaccharides (Ray et at. 
1976). Alterations in the membrane permeability are also possible during 
lyophilization (Sinskey and Silverman 1970). If lyophilization is not possible because 
the survival rates are lower than 0.1 %, or in cases where survival is not an 
essential requirement after storage for prolonged periods, storage in liquid nitrogen 
or at -70 °C may be other suitable alternatives. 
Chlamydia pneumoniae is a recently-described respiratory pathogen (Grayston 
eta/. 1986). It can cause a variety of respiratory infections varying in seriousness 
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from bronchitis to atypical pneumonia (Grayston et a/. 1989). Chlamydia 
trachomatis is a human urogenital pathogen. At present, 18 different serotypes of 
this pathogen are known. Infections with C. trachomatis are among the most 
widely occurring sexually- transmitted diseases (Martin 1990). It is known that both 
Chlamydia species can be preserved for prolonged periods provided that they are 
frozen at a minimum of -70°C. For the optimum survival of C. pneumoniae it is 
necessary to cool the microbe at 4°C for 4 h prior to freezing at -70°C (Kuo and 
Grayston 1988). This method of preservation is unsuitable for the purposes of 
culture collection, is expensive and is very clumsy for transport. The autors have 
therefore attempted to find a suitable medium for optimum survival of Chlamydias 
after lyophilization. Initially C. pneumoniae and C. trachomatis LGV, were frozen 
in at -70 °C or -196 °C in four different media prior to lyophilization. As fetal calf 
serum (FCS) supplemented with glucose offered the highest survival rates, 
additional changes were restricted to other saccharides dissolved in FCS. The rate 
of freezing was also varied during these experiments. 
MATERIAlS AND METHODS 
Chlamydia strains and antigen purification 
Chlamydia trachomatis LGV2 (strain 434/Bu) was propagated in cycloheximide-
treated McCoy cells as described by Rip a and Mardh ( 1977). The McCoy cells were 
seeded in 75-cm 2 tissue culture flasks (Costar, Cambridge, Mass.). After the cells 
had grown to a confluent monolayer they were pre-incubated for 15 min in Hank's 
balanced salt solution (HBSS) supplemented with 15 119/ml DEAE dextran (Sigma). 
The monolayer was subsequently inoculated with C. trachomatis LGV2 • After 
centrifugation at 1200g for 1 h the medium was replaced by Eagle's modification 
of minimal essential medium (Flow) containing 10% fetal calf serum (FCS)(Hyclone 
Laboratories, INC., Logan, Utah). 2 mmol r' glutamine (Flow), 1% vitamins (Flow). 
18 11g ml·' gentamicin, 23 11g mr' vancomycin, 2.5 11g ml·' amphotericin Band 1 119 
mr' cycloheximide (Sigma)(EMEMS). After incubation at 37°C in an atmosphere 
containing 5% C02 for 72 h, cells containing C. trachomatis LGV, were sonicated 
and partially purified by differential centrifugation at 500g for 10 min and at 
30000g for 30 min. The pellet was homogenized in SPG comprising 20 mmol r' 
phosphate buffer containing 0.2 mol 1·' sucrose (Merck) 49 mmol r' glutamine 
(Sigma). 10% FCS, 18 11g mr' gentamicin, 23 11g mr' vancomycin and 2.5 11g ml·' 
amphotericin Band centrifuged at 53000g for 1 h through a 30% urografin solution 
(3.9 g 100 ml·' sodium amidotrizoate, 26 g 100 ml·' meglumine amidotrizoate, 146 
mg 100 ml·' iodine). Chlamydia trachomatis LGV2 elementary bodies were washed 
once with phosphate-buffered saline (PBS) and stored in SPG at -80 °C until use. 
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Chlamydia pneumoniae (strain TW-183) was propagated in Hl cells. Culture 
and purification of C. pneumoniae was the same as that described for C. 
trachomatis LGV, (EBs). Chlamydia pneumoniae EBs were cooled at 4°C for 4 h 
before storage at -80°C. 
Culture and staining 
Tissue culture plates with 24 wells (Greiner, Solingen, Germany) containing Hl cells 
for C. pneumoniae culture or McCoy cells for C. trachomatis LGV, culture were 
treated with Hank's balanced salt solution containing DEAE as described above. 
Monolayers were inoculated with chlamydias, centrifuged at 1200g for 1 h and 
incubated in EMEMS for 72 hat 37°C in an atmosphere containing 5% C02 . After 
incubation, the infected monolayer was fixed with 96% ethanol (Merck). Chlamydia 
trachoma tis LGV 2 inclusions were stained with anti-C. trachomatis monoclonal 
antibody (Microtrak, Syva CO). Chlamydia pneumoniae was stained with anti-C. 
pneumoniae monoclonal antibody (Washington Research Foundation) and 
fluorescein isothiocyanate-labelled goat anti-mouse immunoglobulins (Central 
Laboratory of the Netherlands Red Cross Blood Transfusion Service) in 0.003% 
Evans blue (Sigma). Inclusions were counted with a Leitz Ortholux fluorescent 
microscope. 
lyophilization 
Chlamydias were suspended in different lyophilization media at a concentration of 
1 O' inclusion forming units (IFU) ml·1 and 0.2 ml of Chlamydias containing 
lyophilization medium was diluted with 1.8 ml SPG. Three wells of a 24 wells 
tissue culture plate were inoculated with 0.4 ml of this dilution and cultured as 
described above. The number of IFU per well observed in this control was set at 
100%. Three millilitres of lyophilization medium containing chlamydias at a 
concentration van 106 IFU ml·' was equally divided into 12 glass ampoules and 
frozen. One ampoule was then thawed, diluted 1:10 with SPG and cultured. The 
decrease in the total number of IFU after freezing was determined. The other 
ampoules were lyophilized under 6 x 10·' mbar in an Edwards Super Modulyo 
lyophilizer. The numbers of IFU were determined either after 24 h, or in certain 
cases, 4 months after lyophilization by rehydrating the pellet with distilled water. 
The chlamydias were then diluted 1:10 with SPG and 0.4 ml of this dilution was 
cultured. 
Controls for the freezing procedure were Escherichia coli and Neisseria 
gonorrhoeae (both were patient strains) which were lyophilized in FCS containing 
7.5% glucose and the above protocol. The number of colony forming units was 
determined before and after freezing and after lyophilization of E. coli and N. 
gonorrhoeae on Tryptone Soy Agar (Oxoid) and plates containing G.C. hect Agar 
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(Becton Dickinson) supplemented with antibiotics IDifco) respectively. The results 
were compared with those already reported (Lapage eta!. 1970b). Each experiment 
was performed at least in duplicate. Mean percentages survival are given in the 
results section. 
Variations in the media for lyophilization and the rate of freezing 
Initially, four different media were used for freezing. Skimmed milk and FCS 
containing 7.5% glucose were used because the viability of several bacteria after 
lyophilization was reported to be optimum in these media (Lapage et at. 1970a). 
Yolk-sac and SPG were used because these media have been traditionally used to 
store chlamydias after freezing and because it is known that their viability remains 
satisfactory after thawing (Kuo and Grayston 1988). In addition, during the 
variations in freezing parameters, FCS containing 7.5% saccharose or lactose and 
trehalose were also tested for their suitability as media for lyophilization. 
The ampoules containing chlamydias for lyophilization were frozen in three 
different manners. These were instantaneous freezing in dry ice/methanoi(-70°C). 
snap freezing in liquid nitrogen I-196°C) and strictly controlled freezing at a rate of 
1 °C/min down to -150°C via a Cryoson TRA-5 (Cryoson HiTech, Middenbeemster, 
The Netherlands). 
RESULTS 
The recoveries of C. pneumoniae and C. trachoma/is LGV 2 after lyophilization in 
yolk-sac, SPG, skimmed milk and FCS containing 7.5% glucose are shown in Table 
1. The final temperature after rapid freezing tiii-70°C or -196 °C had no effect on 
the recovery before and after lyophilization. From the media that were tested, the 
highest recovery I± 5.5% recovery) after lyophilization was observed when FCS 
containing 7.5% glucose was used as the preservation medium. Since the survival 
of chlamydias in skimmed milk was already lower than that in the other media after 
freezing, its recovery after lyophilization was thus adversely affected. The 
difference between the survival of C. pneumoniae and C. trachomatis LGV2 when 
yolk-sac was used as the medium for lyophilization was remarkable. The survival 
of C. pneumoniae after freezing in yolk-sac was twice as high. 
The survival of chlamydias after lyophilization was similar when 7.5% 
glucose, lactose and saccharose in FCS were tested for their suitability as a 
protective agents (Tables 1 and 2). In comparison, the recovery was lower when 
trehalose was used as a protective agent. In most cases, controlled freezing at a 
rate of 1 °C min~1 resulted in a slightly higher recovery than that observed via other 
methods of rapid freezing. 
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The size of the chlamydia inoculum (104 to 5x106 IFU mr'), using FCS 
supplemented with 7.5% glucose as lyophilization medium, had no affect on the 
Table I. Influence of preservation media on viability counts before and after 
lyophilization. 
Preservation Bacterial strain Freezing end- Viability (%) 
medium temperature ( °C) Before-lye After-lyo 
Yolk-sac 
C. trachomatis -70 37.0 1 . 1 
2 -196 36.2 1.0 
3 C. pneumoniae -70 80.3 0.8 
4 -196 75.3 0.6 
SPG 
1 C. trachomatis -70 81.2 1.8 
2 -196 76.5 2.1 
3 C. pneumoniae -70 91.0 2.7 
4 -196 88.3 2.6 
Skimmed milk 
1 C. trachomatis -70 55.4 2.6 
2 -196 58.7 2.9 
3 C. pneumoniae -70 45.6 0.9 
4 -196 45.1 1.0 
FCS glucose 
C. trachomatis -70 94.2 5.4 
2 -196 90.3 5.9 
3 C. pneumoniae -70 73.0 4.4 
4 -196 73.5 2.9 
5 E. coli -70 92 75 
6 -196 88 81 
7 N. gonorrhoeae -70 45 10 
8 -196 55 9 
74 
Table II. Viability of chlamydias at different rates of freezing and subsequent 
lyophilization after preservation in FCS containing different saccharides. 
FCS containing Chlamydia strain Rate of Viability 1%1 
freezing Before-lyo After-lyo 
7.5% glucose 
1 trachomatis slow 74.4 5.6 
2 pneumoniae 71.2 6.2 
7.5% saccharose 
1 trachomatis fast 65.1 5.4 
2 slow 77.4 4.9 
3 pneumoniae fast 69.1 3.0 
4 slow 70.8 5.2 
7.5% lactose 
trachoma tis fast 74.9 5.7 
2 slow 76.3 3.8 
3 pneumoniae fast 65.9 1.4 
4 slow 70.7 5.8 
7. 5% trehalose 
1 trachomatis fast 70.1 0.8 
2 slow 86.3 1.9 
3 pneumoniae fast 78.8 1.6 
4 slow 88.4 3.4 
survival after lyophilization (results not shown). In samples that were first frozen 
in FCS supplemented with 7.5% glucose and lyophilized no decrease in the 
numbers of IFU in C. pneumoniae and C. trachomatis LGV 2 was observed after 
storage at 4°C for 4 months (results not shown). 
DISCUSSION 
The factors which have an influence on the survival of micro-organisms during 
lyophilization are very complex and poorly understood. The process of lyophilization 
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may be divided into three steps all of which have an influence on the viability of 
micro-organisms. In the first place the manner of freezing influences the survival, 
followed by the actual lyophilization and finally the manner of rehydration of the 
micro-organisms during the recovery after lyophilization. 
For an optimum recovery, cryoprotective agents are added to the medium 
before microorganisms are frozen (Rightsel and Greiff 1967). The protection that 
these additives offer depends on the exclusion of them from the solution in the 
immediate vicinity of membrane proteins. In the liquid phase and during freezing the 
thermodynamic conditions are thus unfavourable for the denaturation of membrane 
proteins (Carpenter eta/. 1991). A wide variety of chemical compounds such as 
proteins, saccharides and inorganic salts can be used as cryoprotective agents. 
Tables 1 and 2 show that both SPG and FCS containing 7.5% sugar are optimal 
media for the survival of chlamydias after freezing. Skimmed milk appeared to be 
less suitable for freezing, whereas the viability of C. pneumoniae in yolk-sac was 
satisfactory. Previous results showed that the protective effect of SPG in an 
aqueous solution could be ascribed to the serum component {Theunissen et at. 
1992). Table 2 shows that in general, controlled freezing led to a slightly improved 
survival as compared with that after rapid freezing. 
The inactivation of micro-organisms during lyophilization depends on the 
denaturation of membrane proteins by withdrawal of water and is, therefore, 
fundamentally different from inactivation during freezing. The hydrogen bonds 
between membrane proteins and water are split during lyophilization. Thus, for a 
good recovery of microorganisms after lyophilization, the cryoprotective agents in 
the medium must adopt the role of water and re-establish the hydrogen bonds with 
the membrane proteins (Carpenter et a/. 1991). Thus, for any given micro-
organism, there are only one or two suitable cryoprotective agents. A medium 
containing lactose and gelatine was optimum for mycobacteria (Siosarek et a/. 
1976). A medium containing 12% sucrose was optimum for anaerobes (Staab and 
Ely 1987) and a medium containing 0.2 mol 1~ 1 sucrose and 1% bovine serum 
albumin was optimum for respiratory syncytial virus (Tannock eta/. 1987). During 
lyophilization of chlamydias, the particular saccharide that was used hardly affected 
the survival, although trehalose offered less protection than the other saccharides. 
During rehydration of lyophilized bacteria, the viability was affected by the 
medium that was used (Ray eta!. 1976; Valdes eta!. 1985). In the appropriate 
rehydration medium, the repair mechanisms of bacteria were able to restore non-
lethally injured bacteria. Since these repair mechanisms are absent in Chlamydia 
EBs, there was no justification for varying the rehydration medium. 
In comparison with that of the other micro-organisms, the survival of 
chlamydias after lyophilization, was somewhere in the middle. After lyophilization, 
higher survival was observed in among others, E. coli (80%) (MacKenzie 1977; 
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Table 1) and in Varicella Zoster Virus (1 00%) (Grose eta!. 1981). lower survival 
was observed in among others in S. aureus 10.1 %) (Ohmoto eta!. 1988). several 
anaerobes (0.01-0.1 %) (Staab and Ely 1987). Campy!obacter (0.001 %) (Owen et 
a!. 1989) and in a large number of viruses IRightsel and Greiff 1967). 
The recovery of chlamydias was higher after freezing in SPG at -80°C 
compared with lyophilization as a preservation technique. However, because there 
was no decrease of infectious chlamydias on day one and four months after 
lyophilization and because the percentage survival after lyophilization was 
independent of the initial inoculum, even a 5% survival of chlamydias after 
lyophilization may be considered as successful. Nevertheless, the results of this 
study do not exclude the possibility for further improvement in this survival rate. 
Although, long-term survival after lyophilization was not investigated in this study, 
lyophilization appears to be a cheap alternative for storage and transport of 
chlamydias. 
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SUMMARY AND DISCUSSION 
Serological detection of acute Chlamydia trachoma tis infections. 
The development of an enzyme linked immunofluorescent assay (ELFA) for the 
detection of lgG and/or lgM and/or lgA antibodies directed against Chlamydia 
trachomatis is described in chapter 2. With a correlation coefficient of 0.88, the 
sensitivity of the ELFA was almost identical to that of the microimmuno-
!luorescence (MIF) which was used as the reference method. The disadvantages 
of the MIF such as the subjective assessment of the titer and the requirement for 
12 different antigens in the test system (1) were overcome in the ELFA. In the 
ELFA, the results are obtained via an objective optical measurement, whereas the 
number of antigens which are offered lor reaction can be limited to 6. Antibodies 
directed against every C. trachoma/is serovar can be detected using these 6 
antigens (2). 
The possibility of cross-reactions with Chlamydia pneumoniae should be 
taken into account when antibodies directed against C. trachomatis are determined. 
These reactions occur in an enzyme l'lnked immunosorbent assay (ELISA) and are 
attributed to antibodies which are directed against the l'lpopolysaccharide (LPS) of 
C. trachomatis, Chlamydia psittaci or Chlamydia pneumoniae. The cross-reactions 
may be avoided by extracting the LPS with sodium desoxycholate after fixing the 
chlamydias (3). Since unfixed elementary bodies (EBs) shed LPS spontaneously 
upon binding with antibodies (4), the use of unfixed EBs is also another possibility 
to avoid cross-reactions. We used unfixed EBs as an antigen in the ELFA and 
observed that there were no correlations between antibodies directed against C. 
trachomatis and those directed against C. pneumoniae (correlation coefficient 
between 0.0 and 0.1 for lgM and between 0.26 and 0.31 for lgG). 
A sensitivity of 63.8% and a specificity of 58.8% as compared with that 
of cell culture were observed in men with uncomplicated infections using the ELFA 
when the results of lgG, lgM and lgA were combined. lgM antibodies made a minor 
contribution towards the sensitivity of the ELFA in this group of patients. As 
compared with lgG antibodies, lgA antibodies contributed slightly towards the 
sensitivity of the ELFA. This contribution was associated with a decrease in 
specificity. The sensitivity was observed to be 48.9% when only lgG antibodies 
were determined, whereas the sensitivity was observed to be 68.3% when lgG 
and/or lgA antibodies were determined. The specificity decreased from 80.0% to 
61.3%. The sensitivity (48.9%) and the specificity (71.3%) for determining lgA 
antibodies only were observed to be lower than those reported previously by others 
in men with uncomplicated infections (5,6). In these studies sensitivities of 83.0% 
and 94.1% were reported, whereas the specificity in both cases was observed to 
be 78.0%. 
The sensitivity of the ELFA as compared with that of the cell culture ·,n 
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women with uncomplicated C. trachomatis infections was observed to be 88.1% 
when the results of lgG, lgM and lgA were combined. This was higher than that 
observed in men. However, the specificity of the reaction was lower than that in 
men and was observed to be 44.9%. The sensitivity and specificity of the ELFA 
when determining lgG antibodies as compared with that of the cell culture in 
women was found to be 73.8% and 60.2 % respectively. In comparison with the 
results reported by others (7), who found a sensitivity of 91.1% and a specificity 
of 53.0%, the specificity using the ELFA was lower whereas the sensitivity was 
higher. This difference could be attributed to the difference in the negative cut-off 
point. The results of lgM antibody determinations corroborated those already 
reported using other methods, namely that the sensitivity was observed to be low, 
whereas the specificity was observed to be high (8,9). In the group of women also, 
in comparison with the lgG antibodies, lgA antibodies contributed less towards the 
sensitivity. The sensitivity increased from 73.8% to 83.3% for determining lgG 
and/or lgA as compared with only lgG antibodies. The specificity decreased from 
60.2% to 51.0% for lgG and/or lgA as compared with lgG only. 
The sensitivity for determining lgM and/or lgG antibodies directed against C. 
trachoma tis using the cell culture as the reference method was significantly lower 
in the groups of men and women using LGV 2 as the only antigen as compared with 
the sensitivity using the group of selected antigens. In spite of this difference and 
the high sensitivity of the ELFA, it was concluded that determining antibodies in 
patients with an uncomplicated C. trachomatis infections was of no value in tracing 
acute infections. However, the ELFA was suitable for investigating the prevalence 
of C. trachomatis infections in groups with high incidence, namely those consulting 
the outpatient department of the clinic for sexually transmitted diseases (STD). 
Tracing of acute C. trachomatis infections in a group of patients suffering 
from complicated urogenital infections using the ELFA is described in chapter 3. A 
group of patients comprising 49 women with acute pelvic inflammatory disease 
(PI D) was investigated. The results of serology were compared with those of the 
cell culture and the polymerase chain reaction (PCR) using samples obtained from 
the cervix and the urethra. The titers that were observed in the ELFA were 
correlated with those in the MIF. The cut-off point in the MIF for an acute infection 
was described previously ( 1 0). A fourfold increase or decrease in the lgM titer 
and/or a fourfold increase in the lgG titer and/or an lgM titer ;;, 1 :500 (in agreement 
with a MIF titer ;;, 1 :32) and/or an lgG titer ;;, 1:16000 (in agreement with a MIF 
titer;;, 1:5121 was therefore regarded as an indication for an acute C. trachomatis 
infection. An acute C. trachomatis infection was traced in 16 of the 49 patients 
using serology. An infection was detected in 4 of the 49 patients by cell culture 
and in 6 of the 49 patients using the PCR. These numbers were significantly lower 
than that observed in serology. All PCR-positive patients and 3 of the 4 patients 
with positive cell cultures had an antibody titer or a progression in antibody titer 
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which indicated an acute C. trachomatis infection. An acute infection was 
demonstrated in 9 of the 49 patients by serology only. The percentage (32. 7%) of 
C. trachomatis infections observed in the serology in the group of patients with PID 
was higher than the percentage (20.0%) that was observed by others in the direct 
immunofluorescence assay (DFA) using samples obtained from tubae or 
endometrium (11 ). At present, the detection of C. trachomatis antigen in samples 
from tubae or endometrium using the DFA is regarded as the most sensitive method 
for tracing acute C. trachomatis infections in patients with PI D. However, obtaining 
samples from tubae or endometrium is only possible via invasive techniques and is 
often considered as imposing an unnecessary burden on the patients in the 
Netherlands. Serology is a possible non-invasive alternative for tracing acute C. 
trachomatis infections in patients with PID because its sensitivity is at least 
comparable with that of the DFA. 
Transmission of Chlamydia pneumoniae. 
Little is known on the mode of transmission of c. pneumoniae; an organism causing 
respiratory tract infections. Without any doubt, an aqueous intermediate plays a 
role in the survival of C. pneumoniae in the host and in its transmission. Therefore, 
C. pneumoniae must be able to survive the physical changes in the environment. 
The variable physical parameters which may have an influence on the survival of 
C. pneumoniae EBs in aqueous environment were investigated in studies described 
in chapter 4. The infectivity of C. pneumoniae EBs appeared not to be affected at 
pH of between 5 and 8. Infectivity was also not affected by NaCI concentrations 
of higher than 80 mM, temperatures between 0°C and 25°C, variations in the Ca'• 
concentrations of 0.3 mM to 4 mM or in the Mg 2+ concentrations of 0 mM to 2.5 
mM. Rapid inactivation of C. pneumoniae was observed to occur at pH of lower 
than 5 or higher than 8 similar to that reported for Chlamydia psittaci (12), at 
temperatures of higher than 30°C and in the absence of proteins in the suspension 
medium. The protein component had a predominantly stabilizing effect on the 
infectivity of C. pneumoniae EBs. In a suspension medium containing 35 mg/ml 
protein, about 60% infectious EBs were observed after incubation for 48 hours, 
whereas no infectious EBs were observed in suspension medium without any 
protein. It was concluded that the infectivity of C. pneumoniae EBs in an aqueous 
environment was limited and it is likely that its transmission from one host to 
another must occur without delay. 
Since there were indications in the literature that the transmission of C. 
pneumoniae occurred via aerosols ( 13, 14). it was decided to investigate the 
decrease in the survival of C. pneumoniae EBs in aerosols in time at different 
temperatures and at different percentages of relative humidity (RH). The decrease 
in the infectivity or survival in time under these conditions were compared with the 
decrease in the infectivity or the survival of other respiratory tract microorganisms 
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such as Streptococcus pneumoniae, cytomegalovirus and Klebsiella pneumoniae. 
S. faecalis was tested because it could be considered as a positive control, whereas 
C. trachomatis was tested because of an eventual difference between the survivals 
of chlamydias pathogenic for the urogenital tract and the respiratory tract. The 
results showed that the survival of C. pneumoniae in aerosols was optimum at 
temperatures between 15°C and 25°C and 95% RH. Two phases were 
distinguished in the survival curves. First, independent of the temperature or the 
RH, the infectivity of C. pneumoniae EBs was rapidly inactivated during the first 30 
seconds after aerosolization. Thereafter, the inactivation progressed more gradually. 
K. pneumoniae Ia gram-negative respiratory tract pathogen), S. pneumoniae 
Ia gram-positive respiratory tract pathogen) and cytomegalovirus (a respiratory tract 
virus) were inactivated faster than C. pneumoniae in aerosols at 25°C and 95% 
RH. The difference between the respiratory tract pathogen C. pneumoniae and the 
urogenital pathogen C. trachomatis was remarkable. The infectivity of C. 
trachomatis in aerosols decreased faster during the first 30 seconds after 
aerosolization than that of C. pneumoniae. This clearly indicated that C. 
pneumoniae is adapted to the host environment and to its mode of transmission to 
another host. 
It was concluded that transmission of C. pneumoniae from host to host via 
aerosols was possible and progressed most efficiently at high relative humidity. 
long-term storage of Chlamydia. 
Long-term storage of microorganisms is frequently essential for culture collections 
and for preparing vaccines. Cryopreservation is the only method used for long-term 
storage of chlamydias. Since this method is both expensive and laborious, survival 
of chlamydias after lyophilization was investigated in studies described in chapter 
6. The viability of chlamydias was approximately 75% after freezing at -70°C 
115, 16). In comparison, the survival was much lower after lyophilization. A 
suspension of chlamydias in fetal calf serum (FCS) containing 7.5% glucose, 
lactose or saccharose and frozen at a controlled rate resulted in a survival of 5% 
after lyophilization. This survival rate of chlamydias after lyophilization was average 
as compared with that of other microorganisms. After lyophilization, 80% survival 
was observed in Escherichia coli 1171 and 100% survival was observed in varicella 
zoster virus (181. whereas the survival of Staphylococcus aureus (19) and 
Campylobacterpylori 1201 after lyophilization was 0.1% and 0.001% respectively. 
The survival after 4 months was identical to that observed immediately after 
lyophilization. In addition, it was observed that the survival was not dependent on 
the initial inoculum. Therefore, in spite of the low survival, it is still possible to use 
lyophilization for the long-term storage of chlamydias. 
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SAMENVATTING EN DISCUSSIE 
Serologische detectie van acute Chlamydia trachomatis infecties. 
In hoofdstuk twee werd de ontwikkeling van een enzyme linked immunofluorescent 
assay (ELFA) beschreven voor het detecteren van lgG en/of lgM en/of lgA 
antilichamen gericht tegen Chlamydia trachomatis. De gevoeligheid van deze ELFA 
was met een correlatie coefficient van 0.88 nagenoeg gelijk aan die van de 
microimmuunfluorescentie (MIF) die als referentie methode werd gebruikt. De 
nadelen van de MIF namelijk de subjectieve beoordeling van de titer en de noodzaak 
om 12 verschillende antigenen in het testsysteem te gebruiken ( 1), werden in de 
ELFA ondervangen. De uitkomst van de ELFA wordt immers bepaald door een 
objectieve optische meting, terwijl het aantal antigenen dat in de reactie wordt 
aangeboden beperkt kan blijven tot zes. Met deze antigenen kunnen antilichamen 
gericht tegen iedere C. trachomatis serovar bepaald worden (2). 
Bij het bepalen van lgG antilichamen gericht tegen C. trachomatis dient 
rekening te worden gehouden met de mogelijkheid van kruisreacties met Chlamydia 
pneumoniae. Deze reacties treden op b'1j gebruik van een enzyme linked 
immunosorbent assay (ELISA) en zijn toe te schrijven aan antilichamen die gericht 
zijn tegen het lipopolysaccharide (LPS) van C. trachomatis, Chlamydia psittaci en 
Chlamydia pneumoniae. De kruisreacties kunnen worden vermeden door het LPS 
na fixatie van de Chlamydia te extraheren met natrium-desoxycholaat (3). Omdat 
niet gefixeerde Ebs spontaan LPS verliezen bij binding met antilichamen (4). biedt 
het gebruik van niet gefixeerde Ebs ook een mogelijkheid om kruisreacties te 
voorkomen. Het bij de ELFA gebruikte antigeen bestond uit niet gefixeerde EBs. Er 
werden door ons dan ook geen correlaties gevonden tussen antilichamen gericht 
tegen C. trachomatis en antilichamen gericht tegen C. pneumoniae. 
Bij mannen met ongecompliceerde infecties werd met de ELFA een 
sensitiviteit en een specificiteit ten opzichte van de celkweek van respectievelijk 
63.8% en 58.8% bereikt, als de resultaten van lgG, lgM en lgA werden 
gecombineerd. Het aantonen van lgM antilichamen leverde in deze patientengroep 
een zeer geringe bijdrage aan de sensitiviteit van de ELFA. lgA antilichamen in de 
mannenpopulatie leverde, vergeleken met lgG antilichamen, een kleinere bijdrage 
tot de sensitiviteit van de ELFA . Deze bijdrage was bovendien geassocieerd met 
een daling van de specificiteit. De sensitiviteit bij bepalen van aileen lgG 
antilichamen was 48.9% terwijl de sensitiviteit bij bepalen van lgG en/of lgA 
antilichamen 68.3% bedroeg. De specificiteit nam dan at van 80.0% tot 61.3%. 
Bij het bepalen van lgA antilichamen aileen was zowel de sensitiviteit (48.9%) als 
specificiteit (71.3%) lager dan wat door anderen eerder beschreven werd voor 
patienten met ongecompliceerde infecties (5,6). In deze studies werden 
sensitiviteiten van 83.0% en 94.1% gerapporteerd terwijl de specificiteit in beide 
gevallen 78.0% bedroeg. 
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De sensitiviteit van de ELFA ten opzichte van de celkweek was bij vrouwen 
met ongecompliceerde C. trachomatis infecties 88.1% indien de resultaten van lgG, 
lgM en lgA werden gecombineerd. Deze sensitiviteit was hoger dan die bij mannen. 
De specificiteit van de reactie was echter lager dan bij de mannen namelijk 44.9%. 
De sensitiviteit en specificiteit van de ELFA bij bepalen van lgG antilichamen was 
in vrouwen respectievelijk 73.8% en 60.2%. Vergeleken met reeds gepubliceerde 
gegevens van andere auteurs (7) die een sensitiviteit van 91.1% en een specificiteit 
van 53.0% vonden, was de sensitiviteit van de ELFA ten opzichte van de celkweek 
lager terwijl de specificiteit hager was. Dit verschil kon worden toegeschreven aan 
een verschil in negatief afsnijpunt. De resultaten van lgM antilichaambepaling 
kwamen overeen met wat reeds voor andere detectie methoden beschreven is, 
namelijk dat de sensitiviteit laag is terwijl de specificiteit hoog is (8,9). Ook in de 
vrouwengroep leverden lgA antilichamen een kleinere bijdrage tot de sensitiviteit 
vergeleken met lgG antilichamen. De sensitiviteit steeg bij het bepalen van lgG 
en/of lgA van 73.8% tot 83.3% vergeleken met aileen lgG antilichamen. De 
specificiteit daalde bij lgG en/of lgA vergeleken met lgG aileen van 60.2% naar 
51.0%. 
Zowel bij de mannen als bij de vrouwengroep was de sensitiviteit bij het 
bepalen van lgM en/of lgG antilichamen gericht tegen C. trachomatis, met de 
celkweek a is referentiemethode, significant lager bij gebruik van LGV 2 als enig 
antigeen vergeleken met de groep van geselecteerde antigenen. Ondanks dit 
verschil en de hoge gevoeligheid van de ELFA kon geconcludeerd worden dat het 
bepalen van antilichamen in patienten met een ongecompliceerde C. trachomatis 
infectie ongeschikt is voor het traceren van acute infecties. Wei is de ELFA geschikt 
om de prevalentie van C. trachomatis infectie in een bevolkingsgroep met hoge 
incidentie, zoals de populatie die een polikliniek voor SOA bezoekt, te onderzoeken. 
In hoofdstuk drie werden vervolgens met behulp van de ELFA acute infecties 
veroorzaakt door C. trachomatis opgespoord in een patientengroep met 
gecompliceerde urogenitale infecties. Als patientengroep werden 49 vrouwen met 
acute pelvic inflammatory disease (PI D) gekozen. De serologische resultaten werden 
vergeleken met celkweek en polymerase ketting reactie (PCR) verricht op samples 
afkomstig van cervix en urethra. De met de ELFA gevonden titers werden 
gecorreleerd aan die van de MIF. Van de MIF werden de afsnijpunten voor een 
acute infectie reeds eerder beschreven (10). Een viervoudige stijging of daling van 
de lgM titer en/of een viervoudige stijging van de lgG titer en/of een lgM titer;,: 
1/500 (overeenkomend met een MIF titer ;,: 1 /32) en/of een lgG titer;,: 1/16000 
(overeenkomend met een MIF titer ;,: 1 /512) werden daarom als representatief 
beschouwd voor een acute C. trachomatis infectie. Een acute C. trachomatis 
infectie kon bij gebruik van serologie in 16 van de 49 patienten worden 
opgespoord. Met de celkweek werd in vier en met de PCR in zes van de 49 
patienten een infectie gedetecteerd wat significant lager was vergeleken met de 
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serologische resultaten. Aile PCR positieve patienten en drie van de vier celkweek 
positieve patienten vertoonden een antilichaamtiter of een antilichaamtiterverloop 
dat duidde op een acute infectie met C. trachomatis. Bij negen van de 49 patienten 
kon aileen met serologie een acute infectie worden aangetoond. Het percentage C. 
trachomatis infecties dat met serologie in de PID patientengroep kon worden 
gevonden (32. 7%). was hager dan het percentage dat door anderen werd 
gevonden (11) bij gebruik van directe immuunfluorescentie (DFAl op materiaal 
afkomstig van tubae of endometrium (20.0%). De detectie van C. trachomatis 
antigeen door DFA in tubae of endometrium, werd tot nu toe als de meest 
sensitieve methode beschouwd voor het opsporen van acute C. trachomatis 
infecties bij PID patienten. Het verkrijgen van dit antigeen is echter aileen mogelijk 
door invasieve technieken en wordt in de Nederlandse situatie vaak als te belastend 
voor de patient gezien. Daar met behulp van serologie minimaal een vergelijkbare 
sensitiviteit behaald kan worden als met DFA, is serologie een mogelijk niet invasief 
alternatief voor het opsporen van acute C. trachomatis infecties in PID patienten. 
Overdracht van Chlamydia pneumoniae. 
Van C. pneumoniae, een verwekker van luchtweginfecties, is weinig bekend over 
de wijze van overdracht van de ene gastheer op de andere. Een waterige 
intermediair speelt ongetwijfeld een rol bij de overleving van C. pneumoniae in de 
gastheer en bij de overdracht van het organisme. C. pneumoniae moet daarom in 
staat zijn om te overleven bij fysische veranderingen in de omgeving. In hoofdstuk 
vier werd onderzocht wat de grenzen waren van de overleving van C. pneumoniae 
EBs voor enkele fysische variabelen in een waterig milieu. De infectiviteit van C. 
pneumoniae EBs bleek niet be"invloed te worden door een pH tussen de 5 en de 8. 
Ook een NaCI concentratie > 80 mM, een temperatuur van 0 °C- 25 °C, variatie 
van de Ca'+ concentratie van 0.3mM- 4 mM of van de Mg'+ concentratie van 0 
mM- 2.5 mM had geen invloed op de infectiviteit. Snelle inactivatie van C. 
pneumoniae vond plaats bij een pH lager dan 5 of hager dan 8 overeenkomend met 
gegevens voor Chlamydia psittaci (12), bij temperaturen >30 °C en indien het 
suspensiemedium geen eiwit bevatte. Vooral de eiwitcomponent had een 
stabiliserende invloed op de infectiviteit van C. pneumoniae EBs. In een 
suspensiemedium dat 35 mg/ml eiwit bevatte kenna 48 uur incubatie nog ongeveer 
60% infectieuze EBs worden teruggevonden terwijl in een suspensiemedium dat 
geen eiwit bevatte geen infectieuze Ebs meer werden gevonden. Geconcludeerd 
werd dat de infectiviteit van C. pneumoniae Ebs in een waterig milieu gelimiteerd 
is en dat voor overleving een snelle overdracht van het organ is me van de ene op 
de andere gastheer dus waarschijnlijk is. 
Omdat in de literatuur aanwijzingen bestonden die duidden op een overdracht 
van C. pneumoniae door middel van aerosolen (13, 14), werd besloten de afname 
in de tijd van de overleving van C. pneumoniae EBs in aerosolen te onderzoeken bij 
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een verschillende temperaturen en verschillende graden van luchtvochtigheid. De 
afname van de infectiviteit of van de overleving in de tijd werd onder dezelfde 
omstandigheden vergeleken met de afname van de infectiviteit of de overleving van 
andere respiratoire microOrganismen zoals Streptococcus pneumoniae, 
cytomegalovirus en Klebsiella pneumoniae, van Streptococcus faecalis en van C. 
trachomatis. S. faecalis gold als positieve controle. De vergelijking met C. 
trachomatis had als doel een eventueel verschil in overleving tussen een 
uropathogene en een respiratoire chlamydia a ante tonen. Uit de experimenten bleek 
dat C. pneumoniae in aerosolen het beste overleeft bij een temperatuur tussen de 
15 °C en de 25 °C en bij een luchtvochtigheid (RHI van 95%. In de afstervings-
curves waren twee fases te onderscheiden. Eerst vindt er, onafhankelijk van 
temperatuur of RH, een zeer snelle inactivatie van de infectiviteit van C. 
pneumoniae EBs plaats gedurende de eerste 30 seconden na aerosolisatie. Hie rna 
verloopt de inactivatie meer geleidelijk. 
K. pneumoniae (een gram-negatieve respiratoire pathogeen), S. pneumoniae 
(een gram-positieve respiratoire pathogeen) en cytomegalovirus (een respiratoir 
virus) vertoonden allen in aerosolen bij 25 °C en 95 %RH snellere inactivatie curves 
dan C. pneumoniae. Opmerkelijk was het verschil tussen de repiratoire pathogeen 
C. pneumoniae en de urogenitale pathogeen C. trachomatis. De infectiviteit in 
aerosolen van C. trachomatis daalde gedurende de eerste 30 seconden na 
aerosolisatie veel sneller dan de infectiviteit van C. pneumoniae. Dit duidt op een 
duidelijke adaptatie van C. pneumoniae aan het gastheermilieu en aan de 
bijbehorende manier van overdracht naar een andere gastheer. 
Geconcludeerd werd dat een overdracht van C. pneumoniae van gastheer op 
gastheer via aerosolen waarschijnlijk is en dat deze overdracht het meest effectief 
verloopt bij hoge luchtvochtigheid van de omgeving. 
langdurige opslag van Chlamydia. 
Voor onder andere vaccin bereiding en culture collections is langdurige opslag van 
microOganismen vaak een vereiste. Voor Chlamydia is cryopreservatie de enige in 
gebruik zijnde methode voor langdurige opslag van organismen. Aangezien deze 
methode op termijn duur en arbeidsintensief is werd in hoofdstuk zes onderzocht 
wat de overleving van Chlamydia is na lyophilisatie. Na invriezen bij -70 °C bleek 
ongeveer 75% van de Chlamydia nog levensvatbaar (15, 16). Lyophilisatie leverde 
vergeleken hiermee, aanzienlijk lagere overlevingspercentages. Een suspensie van 
Chlamydia in een 7.5% oplossing van glucose, lactose of saccharose in FCS 
gecombineerd met een gecontroleerde manier van invriezen, leidde na lyophilisatie 
tot een overleving van 5%. Vergeleken met andere micro6rganismen is de 
overleving van Chlamydia na lyophilisatie gemiddeld te noemen. Zo vertoonden 
Escherichia coli ( 17) en varicella zoster virus (18) overlevingspercentages van 
respectievelijk 80% en 100% na lyophilisatie, terwijl voor Staphylococcus aureus 
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(19) en Campylobacter pylori (201 overlevingspercentages van resp. 0.1% en 
0.001% werden gevonden. Het percentage overleving na vier maanden was gelijk 
aan het percentage dat gevonden werd onmiddellijk na lyophilisatie. Bovendien 
bleek het overlevingspercentage onafhankelijk te zijn van het oorspronkelijk 
inoculum. Hierdoor is het, ondanks het lage percentage overlevende Chlamydia, 
tach mogelijk om lyophilisatie te gebruiken als methode voor langdurige opslag van 
deze organismen. 
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